<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">67123</article-id><article-id pub-id-type="doi">10.7554/eLife.67123</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-225864"><name><surname>He</surname><given-names>Yujiao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-225865"><name><surname>Yang</surname><given-names>Zhiguo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-225866"><name><surname>Zhao</surname><given-names>Chen-si</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-225868"><name><surname>Xiao</surname><given-names>Zhihui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225867"><name><surname>Gong</surname><given-names>Yu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225869"><name><surname>Li</surname><given-names>Yun-Yi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225870"><name><surname>Chen</surname><given-names>Yiqi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-239530"><name><surname>Du</surname><given-names>Yunting</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225871"><name><surname>Feng</surname><given-names>Dianying</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225872"><name><surname>Altman</surname><given-names>Amnon</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-38813"><name><surname>Li</surname><given-names>Yingqiu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3206-5231</contrib-id><email>lsslyq@mail.sysu.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>MOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University</institution><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution>Center for Cancer Immunotherapy, La Jolla Institute for Immunology</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Zúñiga-Pflücker</surname><given-names>Juan Carlos</given-names></name><role>Reviewing Editor</role><aff><institution>University of Toronto, Sunnybrook Research Institute</institution><country>Canada</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cooper</surname><given-names>Jonathan A</given-names></name><role>Senior Editor</role><aff><institution>Fred Hutchinson Cancer Research Center</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>10</day><month>06</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e67123</elocation-id><history><date date-type="received" iso-8601-date="2021-02-01"><day>01</day><month>02</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-06-03"><day>03</day><month>06</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, He et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>He et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-67123-v3.pdf"/><abstract><p>The nuclear pore complex (NPC) is the sole and selective gateway for nuclear transport, and its dysfunction has been associated with many diseases. The metazoan NPC subcomplex RanBP2, which consists of RanBP2 (Nup358), RanGAP1-SUMO1, and Ubc9, regulates the assembly and function of the NPC. The roles of immune signaling in regulation of NPC remain poorly understood. Here, we show that in human and murine T cells, following T-cell receptor (TCR<bold>)</bold> stimulation, protein kinase C-θ (PKC-θ) directly phosphorylates RanGAP1 to facilitate RanBP2 subcomplex assembly and nuclear import and, thus, the nuclear translocation of AP-1 transcription factor. Mechanistically, TCR stimulation induces the translocation of activated PKC-θ to the NPC, where it interacts with and phosphorylates RanGAP1 on Ser<sup>504</sup> and Ser<sup>506</sup>. RanGAP1 phosphorylation increases its binding affinity for Ubc9, thereby promoting sumoylation of RanGAP1 and, finally, assembly of the RanBP2 subcomplex. Our findings reveal an unexpected role of PKC-θ as a direct regulator of nuclear import and uncover a phosphorylation-dependent sumoylation of RanGAP1, delineating a novel link between TCR signaling and assembly of the RanBP2 NPC subcomplex.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>t cell receptor</kwd><kwd>pkctheta</kwd><kwd>nuclear pore complex</kwd><kwd>phosphorylation</kwd><kwd>rangap1 sumoylation</kwd><kwd>nuclear transport</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31670893</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Yingqiu</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31370886</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Yingqiu</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31170846</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Yingqiu</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004000</institution-id><institution>Guangzhou Science and Technology Program key projects</institution></institution-wrap></funding-source><award-id>201904010445</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Yingqiu</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Guangdong Basic and Applied Basic Research Foundation</institution></institution-wrap></funding-source><award-id>2021A1515010543</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Yingqiu</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007162</institution-id><institution>Guangdong Science and Technology Department</institution></institution-wrap></funding-source><award-id>2020B1212060031</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Yingqiu</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>T-cell receptor signaling actively regulates gating of the nuclear pore complex (NPC) in T cells by inducing translocation of protein kinase C-θ to the NPC to promote the sumoylation of RanGAP1.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Nuclear pore complexes (NPCs) span the nuclear envelope (NE) and mediate nucleo-cytoplasmic exchange. NPC dysfunction has been associated with various human diseases (<xref ref-type="bibr" rid="bib6">Beck and Hurt, 2017</xref>). NPCs in the animal kingdom are ~110 megadalton supramolecular assemblies of multiple copies of ~30 different nuclear pore proteins, termed nucleoporins (NUPs) (<xref ref-type="bibr" rid="bib23">Hampoelz et al., 2019a</xref>; <xref ref-type="bibr" rid="bib38">Lin and Hoelz, 2019</xref>). The elaborate structure of NPCs consists of several biochemically and ultrastructurally defined substructures, namely, cytoplasmic filaments, cytoplasmic and nuclear rings, the inner pore ring, the central transporter region, and the nuclear basket (<xref ref-type="bibr" rid="bib23">Hampoelz et al., 2019a</xref>; <xref ref-type="bibr" rid="bib38">Lin and Hoelz, 2019</xref>; <xref ref-type="bibr" rid="bib52">Otsuka and Ellenberg, 2018</xref>).</p><p>An important component of the cytoplasmic filaments is the RanBP2 subcomplex that consists of RanBP2 (Ran-binding protein 2, Nup358), RanGAP1 (Ran GTPase-activating protein 1) SUMO1, and Ubc9 (SUMO-conjugating enzyme) (<xref ref-type="bibr" rid="bib23">Hampoelz et al., 2019a</xref>; <xref ref-type="bibr" rid="bib38">Lin and Hoelz, 2019</xref>; <xref ref-type="bibr" rid="bib75">Werner et al., 2012</xref>). This subcomplex has multiple functions in nucleo-cytoplasmic transport by establishing a RanGTP gradient across the NE and coordinating recycling of importin-β and reassembly of novel import complexes to promote importin-α/importin-β heterodimer-mediated nuclear import (<xref ref-type="bibr" rid="bib22">Hamada et al., 2011</xref>; <xref ref-type="bibr" rid="bib23">Hampoelz et al., 2019a</xref>; <xref ref-type="bibr" rid="bib27">Hutten et al., 2008</xref>; <xref ref-type="bibr" rid="bib38">Lin and Hoelz, 2019</xref>), serving as a disassembly machine for CRM1-dependent nuclear export complexes (<xref ref-type="bibr" rid="bib55">Ritterhoff et al., 2016</xref>), stabilizing the interaction between the inner and outer Y complex of the cytoplasmic ring in humans (<xref ref-type="bibr" rid="bib71">von Appen et al., 2015</xref>), and controlling NPC assembly beyond nuclei during oogenesis (<xref ref-type="bibr" rid="bib24">Hampoelz et al., 2019b</xref>). RanGAP1 has two forms, i.e., non-sumoylated RanGAP1 that mainly localizes in the cytoplasm, and SUMO1-conjugated RanGAP1 that resides at NPCs (<xref ref-type="bibr" rid="bib46">Matunis et al., 1996</xref>), generated by Ubc9-mediated sumoylation (<xref ref-type="bibr" rid="bib9">Bernier-Villamor et al., 2002</xref>; <xref ref-type="bibr" rid="bib33">Lee et al., 1998</xref>). SUMO1 conjugation of RanGAP1 is required for assembly of the RanBP2 subcomplex (<xref ref-type="bibr" rid="bib23">Hampoelz et al., 2019a</xref>; <xref ref-type="bibr" rid="bib24">Hampoelz et al., 2019b</xref>; <xref ref-type="bibr" rid="bib27">Hutten et al., 2008</xref>; <xref ref-type="bibr" rid="bib29">Joseph et al., 2004</xref>; <xref ref-type="bibr" rid="bib41">Mahajan et al., 1997</xref>; <xref ref-type="bibr" rid="bib54">Reverter and Lima, 2005</xref>; <xref ref-type="bibr" rid="bib55">Ritterhoff et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">von Appen et al., 2015</xref>; <xref ref-type="bibr" rid="bib75">Werner et al., 2012</xref>). However, it is unclear whether receptor signaling and, particularly, immune cell stimuli, regulate RanBP2 subcomplex assembly.</p><p>Protein kinase C-θ (PKC-θ) is a pivotal regulator of T-cell activation. PKC-θ belongs to the novel, calcium-independent subfamily of the PKC enzyme family and is highly expressed in hematopoietic cells, particularly in T cells (<xref ref-type="bibr" rid="bib4">Baier et al., 1993</xref>). Engagement of the T-cell receptor (TCR) together with costimulatory receptors (e.g., CD28) by cognate antigens and costimulatory ligands presented by antigen-presenting cells (APCs) recruits PKC-θ to the center of the T-cell immunological synapse (IS) formed at the T cell–APC contact site, where it mediates activation of the transcription factors nuclear factor kappa B (NF-κB), AP-1, and nuclear factor of activated T-cells (NFAT), leading to T-cell activation, cytokine (e.g., IL-2) production, and acquisition of effector functions (<xref ref-type="bibr" rid="bib5">Baier-Bitterlich et al., 1996</xref>; <xref ref-type="bibr" rid="bib13">Coudronniere et al., 2000</xref>; <xref ref-type="bibr" rid="bib35">Li et al., 2004</xref>; <xref ref-type="bibr" rid="bib37">Lin et al., 2000</xref>; <xref ref-type="bibr" rid="bib53">Pfeifhofer et al., 2003</xref>; <xref ref-type="bibr" rid="bib74">Wang et al., 2015</xref>; <xref ref-type="bibr" rid="bib76">Xie et al., 2019</xref>).</p><p>AP-1 transcription factors have pleiotropic effects, including in different aspects of the immune system such as T-cell activation, Th differentiation, T-cell anergy, and exhaustion (<xref ref-type="bibr" rid="bib3">Atsaves et al., 2019</xref>). To date, unlike the regulation of NF-κB, which has been studied extensively, the regulation of AP-1 by PKC-θ in response to TCR stimulation is incompletely understood. Paradoxically, although PKC-θ deficiency does not obviously impair the TCR-induced activation of c-Jun N-terminal kinase (JNK) nor the expression level of AP-1 in mature T cells, it severely inhibits AP-1 transcriptional activity (<xref ref-type="bibr" rid="bib53">Pfeifhofer et al., 2003</xref>; <xref ref-type="bibr" rid="bib62">Sun et al., 2000</xref>), suggesting the existence of an unknown regulatory layer of TCR-PKC-θ signaling. Hence, further exploring how PKC-θ mediates TCR-induced AP-1 activation is important for understanding T-cell immunity.</p><p>In this study, we reveal that PKC-θ directly regulates the nuclear import function of the NPC, which accounts for the effective, TCR-induced activation of AP-1. We show that PKC-θ promotes the nuclear import process by facilitating the assembly of the RanBP2 subcomplex in T cells. This nuclear import was significantly impaired in PKC-θ-deficient (<italic>Prkcq</italic><sup>−/−</sup> or KO) T cells. Mechanistically, PKC-θ directly interacted with and phosphorylated RanGAP1 at Ser<sup>504</sup> and Ser<sup>506</sup>. RanGAP1 phosphorylation at these two Ser residues, but not sumoylation at Lys<sup>524</sup>, promotes its binding to Ubc9, thereby facilitating the sumoylation of RanGAP1 and, consequently, RanBP2 subcomplex assembly. We further demonstrate that a non-phosphorylatable double mutant (S504A/S506A; AA) of RanGAP1 displayed a significantly reduced sumoylation and blocked TCR-induced nuclear translocation of AP-1, as well as that of NF-κB and NFAT. A RanGAP1-EE mutant (S504E/S506E; EE) that mimics phosphorylation of RanGAP1 displayed an increased sumoylation, and its forced expression rescued TCR-induced c-Jun nuclear translocation in PKC-θ knockdown T cells. Thus, our study demonstrates a novel PKC-θ-mediated, phosphorylation-dependent sumoylation of RanGAP1 as an obligatory step for proper assembly of the RanBP2 subcomplex and, furthermore, establishes a novel mechanism for the regulation of AP-1, NF-κB, and NFAT activation by PKC-θ.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>PKC-θ translocates to the NE and colocalizes with NPCs upon TCR stimulation</title><p>Several PKC isoforms translocate to the NE after phorbol ester (PMA, a diacylglycerol mimetic and PKC activator) treatment (<xref ref-type="bibr" rid="bib12">Collas, 1999</xref>; <xref ref-type="bibr" rid="bib32">Leach et al., 1989</xref>). We therefore examined whether PKC-θ also translocates to the NE in stimulated Jurkat E6.1 T cells, a human leukemic T-cell line widely used for the study of TCR signaling (<xref ref-type="bibr" rid="bib1">Abraham and Weiss, 2004</xref>). By biochemically isolating the NE, we observed that anti-CD3 plus anti-CD28 antibody (Ab) costimulation or stimulation with APCs that were pulsed with a superantigen, staphylococcal enterotoxin E (SEE), promoted PKC-θ translocation to the NE fraction (<xref ref-type="fig" rid="fig1">Figure 1A,B</xref>, respectively). Consistent with previous findings, TCR stimulation also promoted PKC-θ translocation to the plasma membrane (PM) fraction (<xref ref-type="fig" rid="fig1">Figure 1A,B</xref>). In addition, transmission electron microscopy analysis of immunogold-labeled PKC-θ showed its translocation to the cytoplasmic face of the NE in response to anti-CD3 plus anti-CD28 costimulation (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Quantitation showed that after 15 min of stimulation, &gt;20% of total PKC-θ was localized 100 nm or less from the NE and &gt;30% of total PKC-θ was localized 100 nm or less from the PM (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>TCR stimulation promotes PKC-θ colocalization with the NPC and PKC-θ deficiency decreases nuclear import of importin-β1 and Ran and NPC association with importin-β1.</title><p>(<bold>A, B</bold>) Subcellular fractionation of Jurkat E6.1 cells stimulated for 0–15 min with anti-CD3 plus anti-CD28 (<bold>A</bold>) or with superantigen (SEE)-pulsed Raji B cells (<bold>B</bold>) and immunodetection with the indicated antibodies. NE, nuclear envelope; PM, plasma membrane. (<bold>C</bold>) Confocal imaging of PKC-θ (green) and NPCs (Mab414, red) colocalization in representative Jurkat E6.1 cells left unstimulated (US) or stimulated for 15 min with anti-CD3 plus anti-CD28 or with PMA plus Iono. Nuclei are stained with DAPI (blue). Areas outlined by squares in the merged images are enlarged at right. Scale bars, 2 μm. (<bold>D</bold>) Quantification of PKC-θ colocalization with NPCs by Pearson correlation coefficient. Analysis was based on at least three different images covering dozens of cells using the ImageJ software. ****p&lt;0.0001 (one-way ANOVA with post hoc test). (<bold>E, F</bold>) Immunoblot analysis of NPC IPs (Mab414) or whole-cell lysates (WCL) from human primary T cells (<bold>E</bold>) or Jurkat E6.1 cells (<bold>F</bold>) stimulated for 0–30 min with anti-CD3 plus anti-CD28. Control IP with normal IgG is shown in the left lane. Nup62, an NPC component, was used a as loading control for the IPs. The arrowhead indicates the Nup62 protein band. (<bold>G</bold>) Confocal imaging of importin-β1 and Ran in representative wild-type (WT) or <italic>Prkcq<sup>−/−</sup></italic> mouse primary splenic T cells stained with the indicated antibodies. Areas outlined by squares in the merged images are enlarged at right. Scale bars, 2 μm. (<bold>H</bold>) Subcellular fractionation of mouse splenic T cells and immunodetection with the indicated antibodies. (<bold>I</bold>) Immunoblot analysis of NPC IPs (Mab414) or whole-cell lysates (WCL) from unstimulated or anti-CD3 plus anti-CD28-stimulated WT or <italic>Prkcq<sup>−/−</sup></italic> mouse splenic T cells. Control IP with normal IgG is shown in the left lane. (<bold>J, K</bold>) Confocal imaging of importin-β1 and Ran (<bold>J</bold>) and subcellular fractionation (<bold>K</bold>), analyzed as in (<bold>G, H</bold>), of Jurkat E6.1 cells transfected with scrambled siRNA-negative control (siNC) or PKC-θ targeting siRNA (siPKC-θ). Scale bars, 2 μm. (<bold>L</bold>) Immunoblot analysis of NPC IPs (Mab414) or WCL from unstimulated or stimulated Jurkat E6.1 T cells stably expressing a control small hairpin RNA (shRNA) or a PKC-θ targeting shRNA (shPKC-θ), analyzed as in (<bold>I</bold>). Data are representative of three (<bold>A, B, E, F, H, I, K, L</bold>) or two (<bold>C, D, G, J</bold>) biological replicates.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Uncropped western blot for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-67123-fig1-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Row data for <xref ref-type="fig" rid="fig1">Figure 1</xref> and for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-67123-fig1-data2-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig1-v3.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>PKC-θ translocates to the NE following TCR stimulation and PKC-θ deficiency decreases nuclear import of importin β1 and Ran and NPC association with importin β1.</title><p>(<bold>A</bold>) Transmission electron microscopy (TEM) images of PKC-θ labeled by antibody-conjugated gold particles in Jurkat E6.1 cells stimulated for 0–15 min with anti-CD3 plus anti-CD28. The areas outlined by small white squares in middle are enlarged at bottom right corner (black squares). C, cytoplasm; N, nucleus; NE, nuclear envelope; PM, plasma membrane. Scale bars, 500 nm. (<bold>B</bold>) Quantitation of the percentage of gold particles localized ≤100 nm from the NE or from the PM in cells from (<bold>A</bold>). **p&lt;0.01, ****p&lt;0.0001 (one-way ANOVA with post hoc test). (<bold>C</bold>) Confocal imaging of PKC-θ and NPCs colocalization in Jurkat E6.1 cells unstimulated (US) or stimulated for 15 min with superantigen (SEE)-pulsed Raji B cells that have been labeled with Cell Tracker Blue (blue). Areas outlined by squares in the merged images are enlarged at right. Scale bars, 2 μm. (<bold>D, E</bold>) Confocal imaging showing colocalization of endogenous PKC-θ (red) with lamin B1 (green) in representative Jurkat E6.1 cells left unstimulated or stimulated for 15 min with PMA plus Iono (<bold>D</bold>). Nuclei are stained with DAPI (blue). Lamin B1 marks the NE. Scale bars, 2 μm. Pixel intensity along a line from M to N in the merged images is shown in (<bold>E</bold>). (<bold>F</bold>) Quantification of ~30 cells with NE-localized PKC-θ from two biological replicates in (<bold>D</bold>). Each symbol represents an individual T cell. Horizontal lines indicate the mean ± s.e.m. ****p&lt;0.0001 (two-tailed unpaired Student’s t-test). (<bold>G</bold>) Quantification of the N/C ratio of importin β1 (left) and Ran (right) based on analysis of <italic>~</italic>30 cells in about six random fields from two biological replicates of <xref ref-type="fig" rid="fig1">Figure 1G</xref>. Horizontal lines indicate the mean ± s.e.m. ***p&lt;0.001, ****p&lt;0.0001 (two-tailed unpaired Student’s t-test). (<bold>H</bold>) Statistical analysis of importin β1 and Ran in nuclear extract from the experiment of <xref ref-type="fig" rid="fig1">Figure 1H</xref>. Analysis was based on three biological replicates. *p&lt;0.05 (two-tailed unpaired Student’s t-test). (<bold>I</bold>) Statistical analysis of importin β1 binding to NPCs in Mab414 antibody IPs from the experiment of <xref ref-type="fig" rid="fig1">Figure 1I</xref>. Analysis was based on three biological replicates. n.s., not significant, *p&lt;0.05 (one-way ANOVA with post hoc test). (<bold>J</bold>) Quantification of the N/C ratios of importin β1 (left) and Ran (right) based on analysis of <italic>~</italic>30 cells in about six random fields from two biological replicates of <xref ref-type="fig" rid="fig1">Figure 1J</xref>. Horizontal lines indicate the mean ± s.e.m. ***p&lt;0.001, ****p&lt;0.0001 (two-tailed unpaired Student’s t-test). (<bold>K</bold>) Statistical analysis of importin β1 and Ran in nuclear extract from the experiment of <xref ref-type="fig" rid="fig1">Figure 1K</xref>. Analysis as based on three biological replicates. *p&lt;0.05 (two-tailed unpaired Student’s t-test). (<bold>L</bold>) Statistical analysis of importin β1 binding to NPCs (immunoprecipitated with Mab414 antibody) in the experiment shown in <xref ref-type="fig" rid="fig1">Figure 1L</xref>. Analysis was based on three biological replicates. n.s., not significant, *p&lt;0.05 (one-way ANOVA with post hoc test). (<bold>M</bold>) Immunoblot analysis of NPC IPs (Mab414) or WCL from unstimulated or stimulated Jurkat E6.1 T cells transfected with scrambled siRNA-negative control (siNC) or PKC-θ targeting siRNA (siPKC-θ). Data are representative of two (<bold>A–F</bold>) or three (<bold>G–M</bold>) biological replicates.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Uncropped western blot for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-67123-fig1-figsupp1-data1-v3.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig1-figsupp1-v3.tif"/></fig></fig-group><p>Given that NPCs are the important components of the NE, we next determined whether PKC-θ colocalized with NPCs. We stimulated Jurkat T cells with anti-CD3 plus anti-CD28 Abs or with PMA plus a Ca<sup>2+</sup> ionophore, ionomycin (Iono), for 15 min and imaged the cells by confocal microscopy. Staining with an anti-PKC-θ Ab and a monoclonal Ab (Mab414) that recognizes a subset of NPC proteins revealed that stimulation significantly increased PKC-θ colocalization with NPCs (<xref ref-type="fig" rid="fig1">Figure 1C,D</xref>). Similarly, T cells stimulated with SEE-pulsed APCs also displayed partial PKC-θ colocalization with the NPCs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). Immunoprecipitation (IP) with Mab414 showed that costimulation increased PKC-θ binding to NPCs in primary human T cells (<xref ref-type="fig" rid="fig1">Figure 1E</xref>) and in Jurkat T cells (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). When we stimulated T cells with PMA plus Iono, a portion of PKC-θ molecules translocated to the NE (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D-F</xref>). Together, these results demonstrate that TCR stimulation induces PKC-θ translocation to the NE and, more specifically, colocalization and physical association with NPCs, suggesting that PKC-θ may participate in the process of nucleo-cytoplasmic transport.</p></sec><sec id="s2-2"><title>PKC-θ deficiency decreases NPC association of importin-β1</title><p>Importin-β1 and Ran proteins play a key role in nucleo-cytoplasmic transport, and importin-β1 can be specifically recruited to NPCs and then mediate the passage of proteins, including transcription factors such as AP-1, NF-κB, and NFAT, into the nucleus through NPCs (<xref ref-type="bibr" rid="bib67">Tetenbaum-Novatt and Rout, 2010</xref>; <xref ref-type="bibr" rid="bib70">van der Watt et al., 2016</xref>). To determine the physiological relevance of the PKC-θ–NPC association, we first analyzed the cellular distribution of importin-β1 and Ran in resting T cells from wild-type and <italic>Prkcq</italic><sup>−/−</sup> mice. Using confocal microscopy, we found that PKC-θ deletion resulted in a decreased ratio of nuclear-to-cytoplasmic of importin-β1 and Ran (<xref ref-type="fig" rid="fig1">Figure 1G</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>). PKC-θ deletion also resulted in a decreased translocation of importin-β1 and Ran to the nuclear fraction (<xref ref-type="fig" rid="fig1">Figure 1H</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1H</xref>). Next, we assessed the binding of importin-β1 to NPCs. In wild-type T cells, importin-β1 constitutively coimmunoprecipitated with NPCs, and anti-CD3 plus anti-CD28 costimulation significantly increased their association; in contrast, in <italic>Prkcq</italic><sup>−/−</sup> T cells, importin-β1 barely bound to NPCs, regardless of stimulation (<xref ref-type="fig" rid="fig1">Figure 1I</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1I</xref>). Similar results were found when we knocked down PKC-θ expression in Jurkat T cells with a specific small interfering RNA or short hairpin RNA (siPKC-θ or shPKC-θ, respectively) (<xref ref-type="fig" rid="fig1">Figure 1J–L</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1J-M</xref>). These data indicate that PKC-θ deficiency alters both the basal state and TCR-induced nucleo-cytoplasmic transport.</p></sec><sec id="s2-3"><title>PKC-θ binds to RanGAP1 at the NE in a sumoylation-dependent manner</title><p>To further investigate how PKC-θ regulates nuclear transport, we constructed GST-tagged proteins, including nucleoporins, RanGAP1, and other NE proteins, and performed GST pull-down assays to determine whether these proteins can interact with PKC-θ. Among them, GST-RanGAP1 showed the most obvious association and a direct interaction with PKC-θ in unstimulated Jurkat cells lysate (<xref ref-type="fig" rid="fig2">Figure 2A,B</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Reciprocal co-IP from Jurkat T cells showed that PKC-θ weakly interacted constitutively with sumoylated RanGAP1, and costimulation with anti-CD3 plus anti-CD28 Abs markedly increased the association of PKC-θ with both forms of RanGAP1 (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). A significant colocalization of PKC-θ and RanGAP1 in NPCs was also observed in Jurkat T cells after anti-CD3 plus anti-CD28 or PMA plus Iono stimulation (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B,C</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>PKC-θ association with both RanGAP1 and RanGAP1-SUMO1 requires PKC-θ sumoylation.</title><p>(<bold>A</bold>) Scheme for in vitro protein direct binding assay. (<bold>B</bold>) Analysis of direct association between RanGAP1 and PKC-θ using approach in (<bold>A</bold>). GST-fusion proteins were detected by Coomassie blue staining (bottom). (<bold>C</bold>) Immunoblot analysis of PKC-θ or RanGAP1 IPs or WCL from Jurkat E6.1 cells stimulated for 0–15 min with anti-CD3 plus anti-CD28. (<bold>D</bold>) Reciprocal IP analysis of the association between endogenous PKC-θ and transfected Flag-tagged wild-type or mutated RanGAP1 in Jurkat-TAg cells. (<bold>E</bold>) Immunoblot analysis of c-Myc-tagged PKC-θ IPs or WCL from Jurkat-TAg cells that were transiently transfected with wild-type PKC-θ or the indicated PKC-θ mutants. (<bold>F</bold>) Subcellular fractionation of Jurkat-TAg cells transiently transfected with wild-type PKC-θ or the indicated PKC-θ mutants (2KR, K325R/K506R desumoylation mutant; K409R, kinase dead; A148E, constitutive active), followed by immunodetection with the indicated antibodies. (<bold>G</bold>) Immunoblot analysis of c-Myc-tagged PKC-θ IPs or WCL from Jurkat-TAg cells that were transiently transfected with the indicated expression vectors. Data are representative of at least three biological replicates (<bold>B–G</bold>).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Uncropped western blot for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-67123-fig2-data1-v3.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>PKC-θ binds to and colocalizes with RanGAP1 in NE.</title><p>(<bold>A</bold>) Association of PKC-θ with the indicated GST-fusion proteins representing different NPC components demonstrated by a pull-down assay from unstimulated Jurkat E6.1 cell. The recombinant proteins were revealed by Coomassie blue staining. Purple arrows indicate the bands corresponding to GST, GST-fusion proteins. (<bold>B</bold>) Confocal imaging of intracellular of PKC-θ (green) and RanGAP1(red) colocalization in Jurkat E6.1 cells left unstimulated or stimulated for 15 min with anti-CD3 plus anti-CD28 or with PMA plus Iono. Cell nuclei are stained with DAPI. Areas outlined by squares in the merged images are enlarged at right. Scale bar, 2 μm. (<bold>C</bold>) Quantitative analysis of colocalization of PKC-θ with RanGAP1 shown in (<bold>B</bold>). Statistical analysis was based on at least three different colocalization images covering dozens of cells using the ImageJ software. ****p&lt;0.0001 (one-way ANOVA with post hoc test). (<bold>D</bold>) Immunoblot analysis of endogenous PKC-θ IPs from Jurkat-TAg cells, detected by HA antibody. (<bold>E</bold>) Statistical analysis of RanGAP1 binding to PKC-θ in c-Myc antibody IPs from the experiment of <xref ref-type="fig" rid="fig2">Figure 2E</xref>. Analysis was based on three biological replicates. *p&lt;0.05, **p&lt;0.01 (one-way ANOVA with post hoc test). Total RanGAP1 included RanGAP1 and RanGAP1-SUMO1. (<bold>F</bold>) Immunoblot analysis of endogenous RanGAP1 IPs from Jurkat-TAg cells transfected with the indicated c-Myc-tagged PKC-θ expression vectors. Data are representative of three independent experiments. (<bold>G</bold>) Statistical analysis of c-Myc-PKC-θ in nuclear extract from the experiment of <xref ref-type="fig" rid="fig2">Figure 2F</xref>. Analysis was based on three biological replicates. *p&lt;0.05, **p&lt;0.01, ****p&lt;0.0001 (one-way ANOVA with post hoc test). (<bold>H</bold>) Statistical analysis of c-Myc-PKC-θ sumoylation from the experiment of <xref ref-type="fig" rid="fig2">Figure 2G</xref>. Analysis was based on three biological replicates. *p&lt;0.05, ***p&lt;0.001 (one-way ANOVA with post hoc test). Data are representative of three biological replicates.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Uncropped western blot for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-67123-fig2-figsupp1-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>Row data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-67123-fig2-figsupp1-data2-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig2-figsupp1-v3.tif"/></fig></fig-group><p>To elucidate the contribution of sumoylation to the association of RanGAP1 with PKC-θ, we transfected Jurkat T cells with wild-type or non-sumoylated RanGAP1 mutant (RanGAP1-K524R) having an N-terminal Flag tag or a C-terminal HA tag. PKC-θ coimmunoprecipitated efficiently with RanGAP1-K524R (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>), implying that RanGAP1 sumoylation is not required for its interaction with PKC-θ. Next, we mapped the PKC-θ determinants required for its NE translocation and RanGAP1 interaction by transfecting Jurkat T cells with c-Myc-tagged wild-type PKC-θ, a desumoylated mutant PKC-θ−2KR (K325R/K506R) (<xref ref-type="bibr" rid="bib74">Wang et al., 2015</xref>), a constitutively active PKC-θ-A148E mutant, or a catalytically inactive PKC-θ-K409R mutant. Reciprocal IP showed that both the sumoylated and non-sumoylated forms of RanGAP1 interacted more strongly with PKC-θ-A148E than with wild-type PKC-θ, whereas PKC-θ−2KR and PKC-θ-K409R displayed a much weaker interaction, if at all (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E,F</xref>). Following biochemical isolation of the NE, we observed that wild-type PKC-θ translocated to the NE in response to PMA plus Iono stimulation (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>), consistent with the results in <xref ref-type="fig" rid="fig1">Figure 1</xref>. Interestingly, PKC-θ-A148E was constitutively localized to the NE regardless of stimulation, while no apparent NE localization of either PKC-θ−2KR or PKC-θ-K409R was observed even after PMA plus Iono stimulation (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>), consistent with the result in <xref ref-type="fig" rid="fig2">Figure 2E</xref>.</p><p>We next compared the sumoylation of wild-type PKC-θ and its mutants. As expected, wild-type PKC-θ, but not PKC-θ−2KR, was sumoylated (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). Interestingly, PKC-θ-K409R, like PKC-θ−2KR, could not be sumoylated, whereas PKC-θ-A148E was sumoylated more strongly than wild-type PKC-θ (<xref ref-type="fig" rid="fig2">Figure 2G</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1H</xref>), indicating that the catalytic activity of PKC-θ is required for its sumoylation. Combining the results in <xref ref-type="fig" rid="fig2">Figure 2E–G</xref> with the result in <xref ref-type="fig" rid="fig2">Figure 2D</xref>, we conclude that PKC-θ sumoylation, rather than the sumoylation of RanGAP1, was important for their association and that PKC-θ sumoylation is required for its NE translocation.</p></sec><sec id="s2-4"><title>PKC-θ deficiency inhibits the association of RanGAP1 with the NPC by reducing its sumoylation</title><p>Given the association between PKC-θ and RanGAP1, we next explored the physiological significance of this interaction. We first inspected the localization of RanGAP1 in resting T cells from wild-type or <italic>Prkcq</italic><sup>−/−</sup> mice. Confocal microscopy revealed that NE-localized RanGAP1 was decreased in <italic>Prkcq</italic><sup>−/−</sup> T cells, with most RanGAP1 found in the cytosol (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). When we used siPKC-θ to transiently knock down endogenous PKC-θ in Jurkat T cells, the amount of cytosol-localized RanGAP1 increased, while NE-localized RanGAP1 decreased (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Consistent with this result, stimulation of human primary T cells with anti-CD3 plus anti-CD28 or with PMA plus Iono increased the ratio of sumoylated to unsumoylated RanGAP1 (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). A similar increase in this ratio was observed when mouse primary T cells or Jurkat T cells were costimulated with anti-CD3 plus anti-CD28 Abs; however, this increase was not observed when expression of PKC-θ was knocked out or knocked down (<xref ref-type="fig" rid="fig3">Figure 3D,E</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>, respectively; whole-cell lysates [WCL]). Consistently, PKC-θ deficiency also decreased the ratio in resting cells (<xref ref-type="fig" rid="fig3">Figure 3D,E</xref>, respectively; WCL and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>PKC-θ deficiency inhibits RanGAP1 sumoylation and its incorporation into the NPC and TCR-induced nuclear import of c-Jun in mature T cells.</title><p>(<bold>A, B</bold>) Confocal imaging of RanGAP1 (red) and lamin B1 (green) localization in representative unstimulated WT or <italic>Prkcq<sup>−/−</sup></italic> mouse primary T cells (<bold>A</bold>), or in representative unstimulated Jurkat E6.1 cells transfected with siNC or siPKC-θ (<bold>B</bold>). Nuclei are stained with DAPI (blue). Areas outlined by squares in the merged images from (<bold>A</bold>) or (<bold>B</bold>) are enlarged at right in (<bold>A</bold>) or (<bold>B</bold>). Scale bars, 2 μm. Quantification of the ratio of NE/total RanGAP1 based on analysis of <italic>~</italic>30 cells in about six random fields from two biological replicates as presented in (<bold>A</bold>) or (<bold>B</bold>) is shown at far right in (<bold>A</bold>) or (<bold>B</bold>), with each symbol representing an individual cell. Horizontal lines indicate the mean ± s.e.m. ****p&lt;0.0001 (two-tailed, unpaired Student’s t-test). (<bold>C</bold>) Immunoblot analysis of RanGAP1-SUMO1 and RanGAP1 in human primary T cells unstimulated or stimulated for 15 min with anti-CD3 plus anti-CD28 or PMA plus Iono. (<bold>D–F</bold>) Immunoblot analysis of Mab414 IPs or WCL from WT and <italic>Prkcq<sup>−/−</sup></italic> mouse primary splenic T cells (<bold>D</bold>) and thymocytes (<bold>F</bold>) stimulated with or without anti-CD3 plus anti-CD28 for 15 min, or from Jurkat E6.1 cells transfected with siNC or siPKC-θ stimulated for 0–15 min with anti-CD3 plus anti-CD28. (<bold>E</bold>) Statistical analysis of the amount ratio of RanGAP1-SUMO1 to Nup62 or to RanGAP1 in IPs or in WCL from the experiment in (<bold>D</bold>), (<bold>E</bold>), or (<bold>F</bold>) is shown at right in each figure. Analysis was based on three biological replicates for each experiment. n.s., not significant, *p&lt;0.05, **p&lt;0.01 (one-way ANOVA with post hoc test). (<bold>G, I</bold>) Confocal imaging of c-Jun (red) localization in representative WT or <italic>Prkcq<sup>−/−</sup></italic> mouse splenic T cells (<bold>G</bold>) or thymocytes (<bold>I</bold>) unstimulated (US) or stimulated with anti-CD3 plus anti-CD28, costained with anti-lamin B1 (green) and DAPI (blue). Areas outlined by squares in the merged images from (<bold>G</bold>) or (<bold>I</bold>) are enlarged at right in (<bold>G</bold>) or (<bold>I</bold>). Scale bars, 2 μm. Quantitative analysis of the N/C ratio of c-Jun analyzed in ~30 cells in about six random fields from two biological replicates as presented in in (<bold>G</bold>) or (<bold>I</bold>) is shown at far right in (<bold>G</bold>) or (<bold>I</bold>). Each symbol represents an individual cell. Horizontal lines indicate the mean ± s.e.m. n.s., not significant; ****p&lt;0.0001 (one-way ANOVA with post hoc test). (<bold>H, J</bold>) Subcellular fractionation of WT or <italic>Prkcq</italic><sup>-/-</sup> mouse splenic T cells (<bold>H</bold>) or thymocytes (<bold>J</bold>) stimulated for 0–15 min with anti-CD3 plus anti-CD28, followed by immunodetection with the indicated antibodies. Data are representative of two (<bold>A, B, G, I</bold>) or three (<bold>C–F, H, J</bold>) biological replicates.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Uncropped western blot for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-67123-fig3-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Row data for <xref ref-type="fig" rid="fig3">Figure 3</xref> and for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-67123-fig3-data2-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig3-v3.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>PKC-θ deficiency inhibits RanGAP1 sumoylation and its incorporation into the NPC, but does not affect TCR-induced phosphorylation of c-Jun.</title><p>(<bold>A</bold>) Immunoblot analysis of the association between RanGAP1-SUMO1 and NPC in Mab414 IPs, and of the indicated proteins expression in WCL from NC and shPKC-θ Jurkat T cells stimulated for 0–15 min with anti-CD3 plus anti-CD28. (<bold>B</bold>) Statistical analysis of the amount ratio of RanGAP1-SUMO1 to Nup62 or to RanGAP1 in IPs or in WCL under unstimulated condition from the experiment in <xref ref-type="fig" rid="fig3">Figure 3D–F</xref>. Analysis was based on three biological replicates. n.s., not significant, *p&lt;0.05, **p&lt;0.01 (two-tailed unpaired Student’s t-test). (<bold>C, D</bold>) Immunoblot analysis of phospho-c-Jun in lysates of WT or <italic>Prkcq<sup>−/−</sup></italic> mouse peripheral T cells (<bold>C</bold>) or thymocytes (<bold>D</bold>) that were left unstimulated (US) or stimulated with anti-CD3 plus anti-CD28 for 15 min. (<bold>E,F</bold>) Statistical analysis of c-Jun nuclear import from the experiment of <xref ref-type="fig" rid="fig3">Figure 3H</xref>, J. Analysis was based on three biological replicates. n.s., not significant, **p&lt;0.01, ***p&lt;0.001 (two-tailed unpaired Student’s t-test). Immunoblot analysis of NPC IPs (Mab414) or whole-cell lysates (WCL) (<bold>G</bold>) and subcellular fractionation (<bold>H</bold>) of NC or shPKC-θ Jurkat E6.1Jurkat E6.1 T cells stimulated for 0–12 hr with anti-CD3 plus anti-CD28 and immunodetection with the indicated antibodies. Data are representative of three biological replicates.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Uncropped western blot for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-67123-fig3-figsupp1-data1-v3.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig3-figsupp1-v3.tif"/></fig></fig-group><p>Sumoylated RanGAP1 was present in Mab414 NPC IPs prepared from mouse primary peripheral T cells or Jurkat T cells regardless of stimulation, but was largely absent or substantially reduced when these cells were depleted of PKC-θ both in resting and in activated T cells (<xref ref-type="fig" rid="fig3">Figure 3D,E</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>, respectively; IP and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). Together, these results indicate that PKC-θ promotes the sumoylation of RanGAP1 as well as the incorporation of RanGAP1 into the NPC both in resting and activated cells. Interestingly, however, and in contrast to peripheral T cells or Jurkat cells, in <italic>Prkcq</italic><sup>−/−</sup> mouse thymocytes, TCR plus CD28 costimulation appeared to increase the association of RanGAP1 with the NPC (<xref ref-type="fig" rid="fig3">Figure 3F</xref>; IP) as well as its relative increased sumoylation (<xref ref-type="fig" rid="fig3">Figure 3F</xref>; WCL) in a manner that was not affected by PKC-θ deletion, although PKC-θ deficiency did decrease the ratio of RanGAP1-SUMO1 to RanGAP1 in resting thymocytes (<xref ref-type="fig" rid="fig3">Figure 3F</xref>, WCL), similar to the mature T cells (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, WCL). Upon TCR stimulation, ERK phosphorylation was decreased in <italic>Prkcq<sup>−/−</sup></italic> mature T cells (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, WCL), consistent with the finding that PKC-θ activates ERK via RasGRP1-Ras signaling (<xref ref-type="bibr" rid="bib56">Roose et al., 2005</xref>). Notably, the activation of ERK was also reduced in <italic>Prkcq<sup>−/−</sup></italic> thymocytes (<xref ref-type="fig" rid="fig3">Figure 3F</xref>, WCL), consistent with a previous report (<xref ref-type="bibr" rid="bib51">Morley et al., 2008</xref>), but in contrast to another report (<xref ref-type="bibr" rid="bib53">Pfeifhofer et al., 2003</xref>; <xref ref-type="bibr" rid="bib62">Sun et al., 2000</xref>). These apparently contrasting results about the effect of <italic>Prkcq</italic> deletion on ERK activation in thymocytes could be due to the fact that the earlier study <xref ref-type="bibr" rid="bib53">Pfeifhofer et al., 2003</xref>; <xref ref-type="bibr" rid="bib62">Sun et al., 2000</xref> used <italic>Prkcq<sup>−/−</sup></italic> mice on a mixed background, whereas the later study (<xref ref-type="bibr" rid="bib51">Morley et al., 2008</xref>) and ours used mice that were extensively backcrossed on the B6 background. Collectively, these results indicate that PKC-θ controls constitutive RanGAP1 sumoylation in both resting mature and immature T cells, but is critical for the TCR-induced RanGAP1 sumoylation and RanGAP1-SUMO association with NPCs only in mature T cells.</p></sec><sec id="s2-5"><title>PKC-θ deficiency inhibits TCR-induced nuclear import of c-Jun in mature, but not immature T cells</title><p>Given the finding that PKC-θ is required for AP-1 activation in mature T cells, but not in thymocytes (<xref ref-type="bibr" rid="bib62">Sun et al., 2000</xref>) and the difference between thymocytes and peripheral T cells observed above (<xref ref-type="fig" rid="fig3">Figure 3D</xref> vs. <xref ref-type="fig" rid="fig3">Figure 3F</xref>), we considered the possibility that the activation and/or nuclear import of c-Jun, which is a component of AP-1 transcription factor, may display difference in its PKC-θ dependence in mature peripheral T cells vs. thymocytes. Whereas PKC-θ deficiency did not affect TCR-induced phosphorylation of JNK and c-Jun (indicative of its activation) in either mouse splenic T cells or thymocytes (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C,D</xref>), confocal microscopy and nuclear fractionation showed that the TCR-induced nuclear localization of c-Jun was blocked in <italic>Prkcq</italic><sup>−/−</sup> splenic T cells (<xref ref-type="fig" rid="fig3">Figure 3G,H</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>), but remained intact in <italic>Prkcq</italic><sup>−/−</sup> thymocytes (<xref ref-type="fig" rid="fig3">Figure 3I,J</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>), suggesting that PKC-θ regulates the nuclear import of c-Jun through the NPC in mature T cells, but not in thymocytes. To test whether PKC-θ deletion impact is long lasting, we stimulated shPKC-θ cells with anti-CD3 plus anti-CD28 for 0–12 hr. As shown in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1G,H</xref>, after 12 hr stimulation, PKC-θ deletion-induced defects in RanGAP1 sumoylation and its binding to NPCs and c-Jun nuclear translocation still remain. Thus, PKC-θ may promote c-Jun nuclear import, but not its phosphorylation per se, suggesting that it regulates AP-1 activation primarily by controlling the function of the NPC.</p></sec><sec id="s2-6"><title>PKC-θ-mediated phosphorylation of RanGAP1 on Ser<sup>504</sup> and Ser<sup>506</sup> facilitates its sumoylation</title><p>Given the fact that phosphorylation of proteins often regulates their sumoylation (<xref ref-type="bibr" rid="bib25">Hendriks et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Hietakangas et al., 2006</xref>; <xref ref-type="bibr" rid="bib68">Tomasi and Ramani, 2018</xref>), we next explored the possibility that PKC-θ may regulate the sumoylation of RanGAP1 via phosphorylating it. Using a mixture of phospho-Ser- and phospho-Thr-specific antibodies, we found that TCR plus CD28 costimulation increased phosphorylation of RanGAP1 in control Jurkat T cells, but not in PKC-θ knockdown cells (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Furthermore, an in vitro kinase assay demonstrated that PKC-θ immunoprecipitated from Jurkat T cells efficiently phosphorylated RanGAP1 (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), indicating that RanGAP1 is most likely a direct PKC-θ substrate. Mass spectrometry analysis of PKC-θ-phosphorylated RanGAP1 identified five potential phosphorylation serine or threonine sites on RanGAP1 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). Upon mutating each of these residues individually to alanine, we found that mutation both Ser<sup>504</sup> and Ser<sup>506</sup>, but not the three other residues, reduced the phosphorylation of RanGAP1, while phosphorylation of the double mutant S504A/S506A (RanGAP1<sup>AA</sup>) was significantly decreased (<xref ref-type="fig" rid="fig4">Figure 4C,D</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). In the in vitro kinase assay, we detected phosphorylation of truncated GST-RanGAP1<sub>431-587</sub> but not the S504A/S506A double mutant (RanGAP1<sup>AA</sup>; <xref ref-type="fig" rid="fig4">Figure 4E</xref>). Sequence alignment of RanGAP1 from different species showed that S<sup>504</sup> (10/11) and S<sup>506</sup> (8/11) sites and three adjacent serines are conserved (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). A mouse RanGAP1 fragment containing these conserved sites was also phosphorylated by PKC-θ in an in vitro kinase assay (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>). When we calculated the ratio of RanGAP1-SUMO1 to RanGAP1 in the mutant cells, we observed that this ratio was significantly decreased in cells expressing the S504A mutant or the double mutant RanGAP1<sup>AA</sup> and, to a lesser extent, in S506A-expressing cells (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Similar result was also observed when RanGAP1 antibody instead of HA antibody was used to detect HA-RanGAP1 and its SA mutants (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F</xref>). And HA-RanGAP1 and its SA mutants had a much higher expression level than endogenous RanGAP1, which could be caused by a strong promoter of the expression vector and contributed to the low sumoylation ratio of HA-RanGAP1. Together, these findings suggest that PKC-θ-mediated phosphorylation of RanGAP1, particularly on Ser<sup>504</sup>, promotes its sumoylation.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>PKC-θ-mediated sumoylation of RanGAP1 requires its phosphorylation on Ser<sup>504</sup> and Ser<sup>506</sup>.</title><p>(<bold>A</bold>) Immunoblot analysis of serine-phosphorylated RanGAP1 in Jurkat E6.1 T cells transfected with siNC or siPKC-θ, and left unstimulated or stimulated with anti-CD3 plus anti-CD28. (<bold>B</bold>) In vitro PKC-θ kinase assay using PKC-θ immunoprecipitated from Jurkat E6.1 cells and recombinant GST-RanGAP1 as substrate. (<bold>C, D</bold>) Immunoblot analysis of the phosphorylation of transfected wild-type or Ser-mutated HA-tagged RanGAP1 using a mixture of p-Ser- and p-Thr-specific antibodies in Jurkat-TAg cells, which were left unstimulated or stimulated for 15 min with anti-CD3 (<bold>C</bold>). Immunoblotting of the indicated proteins in WCL is shown at bottom. The ratio of phospho-RanGAP1 to immunoprecipitated RanGAP1 is shown in (<bold>D</bold>). Analysis is based on three biological replicates. n.s., not significant, *p&lt;0.05, **p&lt;0.01 (one-way ANOVA with post hoc test). (<bold>E</bold>) In vitro PKC-θ kinase assay as in (<bold>B</bold>), using purified truncated GST-RanGAP1 or GST-RanGAP1 <sup>AA</sup> (S504A/S506A) as substrate. (<bold>F</bold>) Immunoblot analysis of the sumoylation of wild-type or the indicated HA-tagged RanGAP1 mutants in Jurkat-TAg cells using an anti-HA antibody (top panel). The ratios of RanGAP1-SUMO1 to RanGAP1 are shown at the bottom panel. Analysis is based on three biological replicates. n.s., not significant, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 (one-way ANOVA with post hoc test). Data are representative of three biological replicates.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Uncropped western blot for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-67123-fig4-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Row data for <xref ref-type="fig" rid="fig4">Figure 4</xref> and for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-67123-fig4-data2-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig4-v3.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>PKC-θ-dependent phosphorylation of RanGAP1.</title><p>(<bold>A</bold>) Immunoblot analysis of the serine-phosphorylated RanGAP1 in stably transfected control (NC) or shPKC-θ-expressing Jurkat E6.1 T cells left unstimulated or stimulated with anti-CD3 plus anti-CD28. Asterisk indicates a nonspecific protein band. (<bold>B</bold>) Listing of 5 RanGAP1 Ser/Thr phosphorylation sites (red) identified by MS analysis of RanGAP1 phosphorylated in vitro by PKC-θ. (<bold>C</bold>) Immunoblot analysis of the phosphorylation of transfected wild-type or Ser-mutated HA-tagged RanGAP1 using a mixture of p-Ser- and p-Thr-specific antibodies in Jurkat-TAg cells, which were left unstimulated or stimulated for 15 min with anti-CD3 (left). Immunoblotting of the indicated proteins in WCL is shown at bottom. The ratio of phospho-RanGAP1 to immunoprecipitated RanGAP1 is shown in (right). Analysis is based on three biological replicates. n.s., not significant (one-way ANOVA with post hoc test). (<bold>D</bold>) Sequence alignment of RanGAP1 proteins from the indicated species, showing conservation of Ser<sup>504</sup> and Ser<sup>506</sup>. (<bold>E</bold>) In vitro PKC-θkinase assay using recombinant truncated GST-mouse mRanGAP1<sub>463-588</sub> as a substrate. (<bold>F</bold>) Immunoblot analysis of both HA-RanGAP1 and endogenous RanGAP1 in WCL from <xref ref-type="fig" rid="fig4">Figure 4F</xref>, detected by RanGAP1 antibody. Data are representative of three (<bold>A, C, E, F</bold>) or two (<bold>B</bold>) biological replicates.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Uncropped western blot for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-67123-fig4-figsupp1-data1-v3.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig4-figsupp1-v3.tif"/></fig></fig-group></sec><sec id="s2-7"><title>PKC-θ-mediated phosphorylation of RanGAP1 is required for RanBP2/RanGAP1-SUMO1/Ubc9 subcomplex assembly</title><p>The SUMO E2 enzyme Ubc9 directly interacts with and conjugates SUMO1 to RanGAP1 (<xref ref-type="bibr" rid="bib9">Bernier-Villamor et al., 2002</xref>), and the sumoylation of RanGAP1 is essential for assembly of the RanBP2/RanGAP1-SUMO1/Ubc9 subcomplex (<xref ref-type="bibr" rid="bib23">Hampoelz et al., 2019a</xref>; <xref ref-type="bibr" rid="bib24">Hampoelz et al., 2019b</xref>; <xref ref-type="bibr" rid="bib27">Hutten et al., 2008</xref>; <xref ref-type="bibr" rid="bib29">Joseph et al., 2004</xref>; <xref ref-type="bibr" rid="bib41">Mahajan et al., 1997</xref>; <xref ref-type="bibr" rid="bib54">Reverter and Lima, 2005</xref>; <xref ref-type="bibr" rid="bib55">Ritterhoff et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">von Appen et al., 2015</xref>; <xref ref-type="bibr" rid="bib75">Werner et al., 2012</xref>). We therefore hypothesized that PKC-θ-mediated phosphorylation of RanGAP1 might regulate the interaction between Ubc9 and RanGAP1 and, furthermore, that RanGAP1 phosphorylation would be required for assembly of this subcomplex. Hence, we first examined whether RanGAP1 sumoylation affects its binding to Ubc9 and found that a non-sumoylated RanGAP1 mutant (K524R) was still capable of associating with Ubc9 (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Next, we generated two RanGAP1 mutants: One, which was mutated at both its sumoylation (K524R) and phosphorylation (S504A/S506A) sites (HA-RanGAP1<sup>AA</sup>/K524R), and another K524R mutant with a replacement of Ser<sup>504</sup> and Ser<sup>506</sup> PKC-θ phosphorylation sites by a glutamic acid as a phosphorylation mimic (HA-RanGAP1<sup>EE</sup>/K524R). We then analyzed the association of these mutants with Ubc9 by reciprocal co-IP and found that, compared with HA-RanGAP1-K524R, HA-RanGAP1<sup>AA</sup>-K524R showed a decreased association with Ubc9, while HA-RanGAP1<sup>EE</sup>-K524R had a stronger interaction (<xref ref-type="fig" rid="fig5">Figure 5A,B</xref>). This result indicates that RanGAP1 phosphorylation promotes its binding to Ubc9 and provides an explanation for our finding that mutation of the RanGAP1 PKC-θ phosphorylation sites inhibits its sumoylation (<xref ref-type="fig" rid="fig4">Figure 4F</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>PKC-θ-mediated phosphorylation of RanGAP1 is required for its association with Ubc9 and RanBP2.</title><p>(<bold>A, B</bold>) Reciprocal IP analysis of the association between HA-tagged wild-type or K524-mutated RanGAP1 and endogenous Ubc9. RanGAP1 expression was analyzed by anti-HA antibody immunoblotting in WCL (bottom panels). RanGAP1<sup>AA</sup> (S504A/S506A); RanGAP1<sup>EE</sup> (S504E/S506E). (<bold>C–E</bold>) Immunoblot analysis of HA-RanGAP1 IPs (<bold>C</bold>) and Ubc9 IPs or RanBP2 IPs (<bold>D</bold>) from Jurkat-TAg cells transfected with HA-RanGAP1 and HA-RanGAP1 mutants. The ratio of RanGAP1-SUMO1 to RanGAP1 in the WCL of (<bold>C</bold>) and (<bold>D</bold>) is quantified in (<bold>E</bold>); quantification is based on three biological replicates. *p&lt;0.05 (one-way ANOVA with post hoc test). Data are representative of three biological replicates.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Uncropped western blot for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-67123-fig5-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Row data for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-67123-fig5-data2-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig5-v3.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Characterization of the effect of Ser/Glu mutation on RanGAP1.</title><p>(<bold>A</bold>) Immunoblot analysis of both HA-RanGAP1 and endogenous RanGAP1 in WCL from <xref ref-type="fig" rid="fig5">Figure 5(D)</xref>, detected by RanGAP1 antibody. (<bold>B</bold>) Prediction of RanGAP1 stability changes upon mutating Ser<sup>504</sup> and Ser<sup>506</sup> to Glu. Predicted increase of protein stability due to mutations at serine 504 or serine 506 of RanGAP1 to glutamic acid as determined by i-Mutant2.0 (<ext-link ext-link-type="uri" xlink:href="http://folding.biofold.org/i-mutant/i-mutant2.0.html">folding.biofold.org/i-mutant/i-mutant2.0.html</ext-link>). Data are representative of three (<bold>A</bold>) biological replicates.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Uncropped western blot for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-67123-fig5-figsupp1-data1-v3.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig5-figsupp1-v3.tif"/></fig></fig-group><p>Next, we transfected Jurkat T cells with HA-RanGAP1, HA-RanGAP1<sup>AA</sup>, or HA-RanGAP1<sup>EE</sup> and analyzed their association with Ubc9 and RanBP2 by reciprocal co-IP. HA-RanGAP1<sup>AA</sup> bound to Ubc9 and RanBP2 less effectively than non-mutated HA-RanGAP1; in contrast, HA-RanGAP1<sup>EE</sup> bound more effectively to Ubc9 and RanBP2 (<xref ref-type="fig" rid="fig5">Figure 5C,D</xref>). As expected, due to its stronger association with Ubc9, the RanGAP1<sup>EE</sup> mutant protein displayed an increased ratio of RanGAP1-SUMO1 to RanGAP1 relative to the two other RanGAP1 proteins (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Similar result was also observed when HA-RanGAP1<sup>EE</sup> transfected cell lysates was blotted with RanGAP1 antibody instead of HA antibody (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). These results reveal that PKC-θ-mediated phosphorylation of RanGAP1 is essential for assembly of the RanBP2/RanGAP1-SUMO1/Ubc9 subcomplex in NPCs. Intriguingly, in silico analysis showed that replacement of the two PKC-θ phosphorylation sites in RanGAP1 by glutamic acid (S504E/S506E) increased the overall structural stability of RanGAP1 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>); this increased stability likely contributed to the observed increased association between RanGAP1 and Ubc9. Collectively, these findings demonstrate that PKC-θ phosphorylates RanGAP1 to increase its association with Ubc9 and, in turn, the sumoylation of RanGAP1, thereby facilitating assembly of the RanBP2/RanGAP1-SUMO1/Ubc9 subcomplex upon TCR stimulation.</p></sec><sec id="s2-8"><title>RanGAP1<sup>AA</sup> mutant inhibits TCR/CD28-induced AP-1, NF-ATc1, and NF-κB nuclear import and IL-2 production</title><p>Based on the results above (<xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>), we hypothesized that the non-phosphorylatable RanGAP1 mutant (RanGAP1<sup>AA</sup>) will have impaired ability to promote nuclear transport of key TCR-activated transcription factors that are required for productive T-cell activation. As a positive control, we generated a RanGAP1 knockdown Jurkat E6.1 cell line (RanGAP1-KD) having a RanGAP1 mutation with decreased RanGAP1 protein level due to an in-frame nucleotide deletion (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A,B</xref>). We confirmed that expression of this mutant resulted in blocked TCR-induced nuclear translocation of NFATc1, p65 (NF-κB), and c-Jun and c-Fos (AP-1) (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C,D</xref>).</p><p>We next determined whether transfection of the RanGAP1-KD cell line with wild-type RanGAP1 or RanGAP1<sup>AA</sup> can rescue the nuclear translocation of NFATc1, p65, or AP-1, with unedited Jurkat cells serving as a negative control. Using subcellular fractionation (<xref ref-type="fig" rid="fig6">Figure 6A</xref>) or confocal microscopy (<xref ref-type="fig" rid="fig6">Figure 6B,C</xref>), we observed that the defective nuclear translocation of these transcription factors in RanGAP1-KD cells was largely rescued by wild-type RanGAP1, but not by the RanGAP1<sup>AA</sup> mutant. Similarly, while stimulated RanGAP1-KD cells displayed reduced IL-2 production, which is known to require the cooperative activity of the above transcription factors, as compared to control cells, transfection with wild-type RanGAP1 rescued IL-2 production, while RanGAP1<sup>AA</sup> did not (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Moreover, by knocking down endogenous RanGAP1 with two different siRNAs designed to specifically target the 3’-UTR of RanGAP1 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E</xref>), we validated the effect of the RanGAP1-AA mutation on TCR-induced nuclear translocation of the three transcription factors in human primary T cells (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E-G</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Wild-type RanGAP1, but not RanGAP1<sup>AA</sup>, rescues deficient TCR-induced nuclear import of NF-ATc1, NF-κB, AP-1 in RanGAP1 (KD) Jurkat T cells.</title><p>(<bold>A</bold>) Immunoblot analysis of NC (transfected with CRISPR/Cas9 vector expressing a scrambled gRNA) and RanGAP1(KD) (containing an in-frame nucleotide deletion in RanGAP1 gene induced by CRISPR/Cas9 genome editing) Jurkat E6.1 cells transfected with HA-RanGAP1 or HA-RanGAP1<sup>AA</sup>, which were left unstimulated or stimulated for 15 min with anti-CD3 plus anti-CD28, followed by nuclear fractionation and immunodetection with the indicated antibodies. RanGAP1<sup>AA</sup> (S504A/S506A). (<bold>B</bold>) Confocal imaging of the nuclear import of GFP-tagged NF-ATc1, p65 (NF-κB), c-Jun and c-Fos in RanGAP1 (KD) cells cotransfected with HA-RanGAP1 or HA-RanGAP1<sup>AA</sup>, and left unstimulated or stimulated with anti-CD3 plus anti-CD28. Scale bars, 3 μm. (<bold>C</bold>) Quantification of the nuclear import of GFP-tagged NF-ATc1, p65 (NF-κB), c-Jun and c-Fos in ~30 cells from two biological replicates as presented in (<bold>B</bold>). Each symbol represents an individual T cell. Horizontal lines indicate the mean ± s.e.m. n.s., not significant, ****p&lt;0.0001 (one-way ANOVA with post hoc test). (<bold>D</bold>) Enzyme-linked immunosorbent assay of IL-2 in supernatants of NC or RanGAP1 (KD) cells transfected with HA-RanGAP1 or HA-RanGAP1<sup>AA</sup> and left unstimulated or stimulated for 24 hr with anti-CD3 plus anti-CD28. n.s., not significant, ****p&lt;0.0001 (one-way ANOVA with post hoc test). Data are representative of three (<bold>A, D</bold>) or two (<bold>B, C</bold>) biological replicates.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Uncropped western blot for <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-67123-fig6-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Row data for <xref ref-type="fig" rid="fig6">Figure 6</xref> and for <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-67123-fig6-data2-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig6-v3.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>RanGAP1 is required for TCR-induced nuclear import of NF-ATc1, NF-κB, and AP-1.</title><p>(<bold>A</bold>) RanGAP1 expression in negative control (NC, cells transfected with scrambled gRNA) Jurkat E6.1 T cells or cells with stable CRISPR/Cas9-edited RanGAP1 knockdown (KD). (<bold>B</bold>) Sequence alignment of RanGAP1 genomic fragment (WT) and the CRISPR/Cas9-edited RanGAP1 genomic fragment in the RanGAP1 (KD) Jurkat T cell line (top). The underlined sequence represents the guide RNA. The mRNA expression levels of RanGAP1 in NC and RanGAP1 (KD) T cells are shown at the bottom. Horizontal lines indicate the mean ± s.e.m. n.s., ***p&lt;0.001 (two-tailed unpaired Student’s t-test). (<bold>C</bold>) Confocal imaging showing the nuclear import of GFP-tagged NF-ATc1, p65 (NF-κB), c-Jun and c-Fos in NC and RanGAP1 (KD) T cells unstimulated or stimulated with anti-CD3 plus anti-CD28. Scale bars, 2 μm. These images are representative of ~30 cells analyzed in each group from two biological replicates. (<bold>D</bold>) Quantification of the nuclear import of GFP-tagged NF-ATc1, p65 (NF-κB), c-Jun, and c-Fos as presented in (<bold>C</bold>). Each symbol represents an individual T cell. Horizontal lines indicate the mean ± s.e.m. n.s., not significant, ***p&lt;0.0001 (one-way ANOVA with post hoc test). (<bold>E</bold>) The knockdown effect of siRanGAP1 in human primary T cells. (<bold>F</bold>) Confocal imaging showing the nuclear import of transfected GFP-tagged NF-ATc1, p65 (NF-κB) or c-Jun in human primary T cells cotransfected with siNC or siRanGAP1 (siRNA 1 + 2), unstimulated or stimulated with anti-CD3 plus anti-CD28. Scale bars, 2 μm. These images are representative of ~30 cells analyzed in each group from two biological replicates. (<bold>G</bold>) Quantification of the nuclear import of GFP-tagged NF-ATc1, p65 (NF-κB), c-Jun as presented in (<bold>F</bold>). Each symbol represents an individual T cell. Horizontal lines indicate the mean ± s.e.m. n.s., not significant, ****p&lt;0.0001 (one-way ANOVA with post hoc test). Data are representative of three (<bold>A, E</bold>) or two (<bold>C, D, F, G</bold>) biological replicates.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Uncropped western blot for <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-67123-fig6-figsupp1-data1-v3.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig6-figsupp1-v3.tif"/></fig></fig-group></sec><sec id="s2-9"><title>PKC-θ-RanGAP signaling axis is differentially required in various nuclear transport pathways</title><p>To determine whether the nuclear transport defect resulting from PKC-θ deficiency is a generalized effect, we compared the nuclear transport of additional proteins in wild-type or PKC-θ knockdown Jurkat T cells (<xref ref-type="fig" rid="fig7">Figure 7</xref>). The proteins we tested were as follows: RNA exosome complex subunit Dis3, ribosome subunits RPS3 and RPL26, tumor suppressor p53, histone H1, which are importin-β1-dependent; histones (H2B, H3), protein/RNA export receptor CRM1, which are Ran-dependent but importin-β1-independent; and Ran-independent mRNA export receptor NXF1 (<xref ref-type="bibr" rid="bib8">Bernardes and Chook, 2020</xref>; <xref ref-type="bibr" rid="bib61">Serpeloni et al., 2011</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>PKC-θ-RanGAP signaling axis is differentially required in various nuclear transport pathways.</title><p>(<bold>A</bold>) Subcellular fractionation of Jurkat E6.1 cells transfected with siNC or siPKC-θ and stimulated for 0–15 min with anti-CD3 plus anti-CD28, followed by immunodetection with the indicated antibodies. (<bold>B</bold>) Statistical analysis of the indicated proteins in nuclear extract from the experiment of (<bold>A</bold>). n.s., not significant, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 (two-tailed, unpaired Student’s t-test). Data are representative of three biological replicates.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Uncropped western blot for <xref ref-type="fig" rid="fig7">Figure 7</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-67123-fig7-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Row data for <xref ref-type="fig" rid="fig7">Figure 7</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-67123-fig7-data2-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig7-v3.tif"/></fig><p>In resting T cells, PKC-θ knockdown led to reduced nuclear import of Dis3, RPS3, and RPL26, as well as impaired nuclear export of CRM1, consistent with their requirement for importin-β1 or the Ran system; however, the Ran-independent NXF1 also displayed impaired nuclear export (i.e., nuclear retention) (<xref ref-type="fig" rid="fig7">Figure 7A,B</xref>). In TCR-activated cells, PKC-θ knockdown did not affect the nuclear transport of CRM1, Dis3, RPS3, or RPL26 (<xref ref-type="fig" rid="fig7">Figure 7A,B</xref>). However, TCR stimulation did not alleviate siPKC-θ-caused defects in importin-β1 nuclear import and in NXF1 nuclear export. Interestingly, independent of the stimulation status, PKC-θ knockdown did not affect the nuclear transport of histones, nor did it affect the nuclear import of stimulation-induced p53. In summary, neither PKC-θ nor TCR signaling regulates histones transport; in resting T cells, the importin-β1- or Ran-dependent nuclear transport pathways we tested, with the exception of histones, are dependent on PKC-θ; in activated cells, PKC-θ was dispensable for their nuclear transport, except for the nuclear transport of importin-β1; and PKC-θ was required for NXF1 transport under both statuses. Therefore, PKC-θ-RanGAP signaling axis is differentially required in various nuclear transport pathways.</p></sec><sec id="s2-10"><title>RanGAP1<sup>EE</sup> mutant rescues c-Jun nuclear import in PKC-θ-deficient T cells upon TCR stimulation</title><p>To further confirm our finding that the defective nuclear import of AP-1, NF-AT, and NF-κB transcription factors in PKC-θ-deficient cells is linked to the impaired phosphorylation of RanGAP1, we next determined whether a phospho-mimic RanGAP1<sup>EE</sup> mutant can rescue the nuclear translocation of c-Jun (AP-1), NF-ATc1 (NFAT), or p65 (NF-κB) in PKC-θ-deficient T cells. We transfected PKC-θ knockdown Jurkat T cells or retrovirally transduced murine splenic <italic>Prkcq</italic><sup>−/−</sup> T cells with RanGAP1 EE or the negative control AA mutant expression vectors and analyzed their effect. As expected, the nuclear import of importin-β1 was partially rescued by RanGAP1<sup>EE</sup> both before or after TCR stimulation in siPKC-θ T cells (<xref ref-type="fig" rid="fig8">Figure 8A</xref>), consistent with our results that PKC-θ is required for RanGAP1 SUMOylation in both states (<xref ref-type="fig" rid="fig1">Figures 1G–L</xref> and <xref ref-type="fig" rid="fig3">3D–F</xref>). Moreover, in contrast to RanGAP1<sup>AA</sup> mutant, RanGAP1<sup>EE</sup> mutant did rescue TCR-induced nuclear translocation of c-Jun in siPKC-θ Jurkat T cells (<xref ref-type="fig" rid="fig8">Figure 8A</xref>) or in <italic>Prkcq</italic><sup>−/−</sup> primary T cells (<xref ref-type="fig" rid="fig8">Figure 8B,C</xref>). The incomplete rescue of c-Jun translocation may be explained by other NPC functional defects caused by PKC-θ deficiency. As expected, NFATc1 or p65 nuclear import was not rescued by the RanGAP1<sup>EE</sup> mutant, consistent with the fact that TCR-proximal upstream signaling pathways are also disrupted in PKC-θ-deficient T cells (<xref ref-type="bibr" rid="bib53">Pfeifhofer et al., 2003</xref>; <xref ref-type="bibr" rid="bib62">Sun et al., 2000</xref>). As to the mRNA export receptor NXF1, siPKC-θ-induced nuclear retention (<xref ref-type="fig" rid="fig7">Figure 7</xref>) was reversed by forced RanGAP1<sup>EE</sup> expression (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). Thus, we conclude that formation of the RanBP2 subcomplex is the key step downstream of PKC-θ signaling that regulates the nuclear transport of transcription factors, especially c-Jun.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>RanGAP1<sup>EE</sup>, but not RanGAP1<sup>AA</sup>, rescues TCR-induced nuclear import of c-Jun in PKC-θ-deficient cells.</title><p>(<bold>A</bold>) Immunoblot analysis of Jurkat-TAg cells cotransfected with siNC or siPKC-θ plus HA-RanGAP1<sup>AA</sup> or HA-RanGAP1<sup>EE</sup> as indicated, which were left unstimulated or stimulated for 15 min with anti-CD3, followed by nuclear fractionation and immunodetection with the indicated antibodies. (<bold>B</bold>) Confocal imaging showing the nuclear import of c-Jun, NF-ATc1 or p65 (NF-κB) in wild-type (WT) murine splenic T cells transduced with GFP-vector or <italic>Prkcq<sup><italic>−</italic>/<italic>−</italic></sup></italic> murine splenic T cells transduced with GFP-vector or RanGAP1<sup>AA</sup> or RanGAP1<sup>EE</sup>, left unstimulated or stimulated with anti-CD3 plus anti-CD28 for 15 min. Scale bars, 2 μm. These images are representative of ~30 cells analyzed in each group in two independent experiments. (<bold>C</bold>) Quantification of the nuclear import of c-Jun, NF-ATc1, or p65 as presented in (<bold>B</bold>). Each symbol represents an individual T cell. Horizontal lines indicate the mean ± s.e.m. n.s., not significant, ****p&lt;0.0001 (one-way ANOVA with post hoc test). Data are representative of two biological replicates.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Uncropped western blot for <xref ref-type="fig" rid="fig8">Figure 8</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-67123-fig8-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig8sdata2"><label>Figure 8—source data 2.</label><caption><title>Row data for <xref ref-type="fig" rid="fig8">Figure 8</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-67123-fig8-data2-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig8-v3.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>PKC-θ plays an indispensable role in T-cell activation, including the TCR-induced activation of NF-κB, AP-1, and NFAT, the main transcription factors required for acquisition of effector functions and cytokine production of T cells (<xref ref-type="bibr" rid="bib2">Altman and Kong, 2016</xref>; <xref ref-type="bibr" rid="bib53">Pfeifhofer et al., 2003</xref>; <xref ref-type="bibr" rid="bib62">Sun et al., 2000</xref>). These PKC-θ-dependent functions depend on its recruitment to the T-cell IS and its association with CD28 (<xref ref-type="bibr" rid="bib31">Kong et al., 2011</xref>). However, little is known about potential nuclear functions of PKC-θ, with the exception of a few studies that demonstrated a role for nuclear and chromatin-associated PKC-θ in promoting gene expression (<xref ref-type="bibr" rid="bib36">Li et al., 2016</xref>; <xref ref-type="bibr" rid="bib63">Sutcliffe et al., 2011</xref>). Here, we have demonstrated that upon TCR plus CD28 costimulation, PKC-θ phosphorylates RanGAP1 to promote its interaction with Ubc9 and increase the sumoylation of RanGAP1, which, in turn, enhances assembly of the RanBP2 subcomplex and, thus, directly promotes the nuclear import of AP-1, NFAT, and NF-κB (<xref ref-type="fig" rid="fig9">Figure 9</xref>). Thus, our work reveals a novel signaling axis, TCR-PKC-θ-RanGAP1, which regulates T-cell activation via control of nucleo-cytoplasmic transport, thereby linking TCR signaling to formation of the NPC.</p><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Schematic model of nuclear import regulation by the TCR-PKC-θ-RanGAP1 axis.</title><p>Upon TCR stimulation, PKC-θ phosphorylates RanGAP1 to increase its association with Ubc9, thereby enhancing the sumoylation of RanGAP1, which is required for assembly of the RanBP2/RanGAP1-SUMO1/Ubc9 subcomplex. This complex then promotes the nuclear import of NF-ATc1, NF-κB, and AP-1.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67123-fig9-v3.tif"/></fig><p>Evidence for crosstalk between NPC components and immunological signaling is emerging (<xref ref-type="bibr" rid="bib10">Borlido et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Gu et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Liu et al., 2015</xref>), yet much remains unknown. While the sumoylation of RanGAP1 is essential for the assembly and function of the RanBP2 complex (<xref ref-type="bibr" rid="bib47">Matunis et al., 1998</xref>; <xref ref-type="bibr" rid="bib57">Saitoh et al., 1997</xref>), the signals that regulate this sumoylation are unclear. The sumoylation of target proteins is generally highly transient, but RanGAP1 is an exception in that it is constitutively sumoylated (<xref ref-type="bibr" rid="bib41">Mahajan et al., 1997</xref>; <xref ref-type="bibr" rid="bib57">Saitoh et al., 1997</xref>), a result of Ubc9 directly recognizing and catalyzing sumoylation of the RanGAP1 φ-K-x-D/E consensus motif at amino acid residues 525–528 (<xref ref-type="bibr" rid="bib9">Bernier-Villamor et al., 2002</xref>; <xref ref-type="bibr" rid="bib33">Lee et al., 1998</xref>; <xref ref-type="bibr" rid="bib77">Zhu et al., 2006</xref>). The inter-regulation between phosphorylation and sumoylation is a common mechanism for the regulation of protein function (<xref ref-type="bibr" rid="bib26">Hietakangas et al., 2006</xref>; <xref ref-type="bibr" rid="bib68">Tomasi and Ramani, 2018</xref>). Several Ser/Thr phosphorylation sites have been identified in RanGAP1, including the phosphorylation of Ser<sup>358</sup> by casein kinase II kinase to promote RanGAP1 binding to Ran protein (<xref ref-type="bibr" rid="bib66">Takeda et al., 2005</xref>), phosphorylation of Thr<sup>409</sup>, which is related to the nuclear accumulation of cyclin B1 (<xref ref-type="bibr" rid="bib65">Swaminathan et al., 2004</xref>), and mitotic phosphorylation of Ser<sup>428</sup> and Ser<sup>442</sup> with unknown function (<xref ref-type="bibr" rid="bib65">Swaminathan et al., 2004</xref>). However, none of these phosphorylations affect the sumoylation of RanGAP1. In contrast, phosphorylation of Ser<sup>504</sup> and Ser<sup>506</sup> by PKC-θ, which we documented here, promoted the sumoylation of RanGAP1 by enhancing the interaction between RanGAP1 and Ubc9, which may be facilitated by these two phosphorylation sites being close to the φ-K-x-D/E motif. Thus, our study suggests a unique role for PKC-θ in linking TCR signaling to assembly of the RanBP2 complex.</p><p>Our finding that PKC-θ deficiency essentially abolished the binding of RanGAP1-SUMO1 to NPC while only moderately inhibiting the sumoylation of RanGAP1 upon stimulation in vivo (<xref ref-type="fig" rid="fig3">Figure 3D,E</xref>) is of interest. A possible explanation for this apparent discrepancy is that the increased RanGAP1 phosphorylation itself, mediated by PKC-θ upon stimulation, may also assist the binding. Moreover, other PKC-θ substrates in addition to RanGAP1 may exist in the NPC complex; thus, phosphorylation of these proteins by PKC-θ may contribute to the TCR-induced NPC assembly as well. The T-cell adaptor protein, SLP76, has been reported to bind to RanGAP1-SUMO1 and to promote the TCR-induced nuclear import of NFAT (<xref ref-type="bibr" rid="bib39">Liu et al., 2015</xref>). Combining these findings, we propose that some TCR signaling modules, e.g., PKC-θ and SLP76, translocate to the NE to regulate nucleo-cytoplasmic transport and, furthermore, that PKC-θ plays an indispensable role in NPC assembly.</p><p>One explanation for our observation that generally importin-β1 or Ran-dependent nuclear transport of proteins was mostly unaffected in PKC-θ-deficient cells (<xref ref-type="fig" rid="fig7">Figure 7</xref>) is that other transport pathways may play a compensatory role in the absence of PKC-θ, especially under stimulation conditions. The RanBP2/RanGAP1-SUMO1/Ubc9 subcomplex is thought to have evolved to facilitate efficient nuclear transport but not a prerequisite complex for nuclear transport per se because RanBP2 is only found in the animal kingdom and SUMO modification does not apply to plant RanGAP1 (<xref ref-type="bibr" rid="bib27">Hutten et al., 2008</xref>). In addition, soluble RanGAP1 may function as a substitute for RanBP2-associated RanGAP1-SUMO1 to promote nuclear transport (<xref ref-type="bibr" rid="bib27">Hutten et al., 2008</xref>). Of note, in both resting and activated siPKC-θ T cells, RanGAP1-SUMO1 was indispensable for the nuclear import of importin-β1, indicating that the integrity of the RanBP2 subcomplex is essential for importin-β1 nuclear import, consistent with previous observations (<xref ref-type="bibr" rid="bib27">Hutten et al., 2008</xref>). Interestingly, the Ran-independent mRNA export receptor NXF1 was also retained in the nucleus in PKC-θ knockdown cells and this retention could be reversed by forced RanGAP1<sup>EE</sup> expression, suggesting that a some other activity (the SUMO E3 ligase activity) other than the GTPase activity of RanBP2 subcomplex is involved (<xref ref-type="bibr" rid="bib55">Ritterhoff et al., 2016</xref>).</p><p>Despite the fact that PKC-θ is required for TCR-induced T-cell activation in vitro (<xref ref-type="bibr" rid="bib53">Pfeifhofer et al., 2003</xref>; <xref ref-type="bibr" rid="bib62">Sun et al., 2000</xref>), PKC-θ deficiency has a different impact on immune responses against in vivo bacterial (<xref ref-type="bibr" rid="bib59">Sakowicz-Burkiewicz et al., 2008</xref>), viral (<xref ref-type="bibr" rid="bib7">Berg-Brown et al., 2004</xref>; <xref ref-type="bibr" rid="bib20">Giannoni et al., 2005</xref>; <xref ref-type="bibr" rid="bib44">Marsland et al., 2005</xref>; <xref ref-type="bibr" rid="bib43">Marsland et al., 2004</xref>) and helminth infections or model allergens (<xref ref-type="bibr" rid="bib43">Marsland et al., 2004</xref>; <xref ref-type="bibr" rid="bib60">Salek-Ardakani et al., 2005</xref>). Specifically, PKC-θ is required for Th2 cell differentiation and Th2-mediated immune responses against helminth and for the proliferation and survival of pathogen-specific T Cells in murine listeriosis (<xref ref-type="bibr" rid="bib43">Marsland et al., 2004</xref>; <xref ref-type="bibr" rid="bib59">Sakowicz-Burkiewicz et al., 2008</xref>). By contrast, PKC-θ is largely dispensable for Th1 differentiation and CD4 Th1/CD8 T cells-mediated resistance against viral and intracellular protozoan <italic>Leishmania major</italic> infection (<xref ref-type="bibr" rid="bib7">Berg-Brown et al., 2004</xref>; <xref ref-type="bibr" rid="bib20">Giannoni et al., 2005</xref>; <xref ref-type="bibr" rid="bib44">Marsland et al., 2005</xref>; <xref ref-type="bibr" rid="bib43">Marsland et al., 2004</xref>). One possible explanation is that strong signals including high antigen dose, TLR ligands, and proinflammatory cytokines (such as IL-1 and TNFα) produced during Th1 and CD8 T-cell responses may well compensate for the loss of PKC-θ signaling (<xref ref-type="bibr" rid="bib2">Altman and Kong, 2016</xref>; <xref ref-type="bibr" rid="bib42">Manicassamy et al., 2006</xref>; <xref ref-type="bibr" rid="bib45">Marsland and Kopf, 2008</xref>). Considering the phosphorylation defect of RanGAP1 in PKC-θ deficient T cells, it might be reversed by a compensatory kinase-mediated phosphorylation of RanGAP1 in response to strong signals. In addition, we speculated the cargo selectivity of importins in regulation of nuclear transport might also contribute to the different requirements for PKC-θ in various T-cell immune responses. It is known that STAT1 transcription factor mediates IFN-γ signaling for Th1 differentiation while AP-1 transcription factors are required for IL-4/10 production in Th2 differentiation (<xref ref-type="bibr" rid="bib34">Li et al., 1999</xref>; <xref ref-type="bibr" rid="bib73">Wang et al., 2005</xref>). It has also been demonstrated that the nuclear import of AP-1 requires importin-β and Ran but is independent of importin-α (<xref ref-type="bibr" rid="bib18">Forwood et al., 2001</xref>)，whereas STAT1 can constitutively transport into the nucleus independent of importin-β (<xref ref-type="bibr" rid="bib50">Meyer et al., 2002</xref>). Thus, the PKC-θ-induced association of RanGAP1 with importin-β might be less important in IFN-γ signaling of Th1 cells but is indispensable in IL-4/10 signaling of Th2 cells. Further studies by rescuing the function of RanGAP1 in <italic>Prkcq</italic><sup>−/−</sup> mice may help to understand the differential requirement for PKC-θ in T cells immune responses.</p><p>During thymocyte-positive selection, PKC-θ is not required for TCR-induced activation of NF-κB and calcium signaling, which may be compensated by other PKC isoforms, such as PKCη (<xref ref-type="bibr" rid="bib2">Altman and Kong, 2016</xref>; <xref ref-type="bibr" rid="bib19">Fu et al., 2011</xref>; <xref ref-type="bibr" rid="bib51">Morley et al., 2008</xref>; <xref ref-type="bibr" rid="bib62">Sun et al., 2000</xref>). Similarly, in contrast to mature T cells, TCR-induced assembly of RanBP2 subcomplex and nuclear import of c-Jun are relatively intact in <italic>Prkcq</italic><sup>−/−</sup> thymocytes (<xref ref-type="fig" rid="fig3">Figure 3D,F,J</xref>), confirming the existence of compensation for PKC-θ in thymocytes. However, the irreplaceable role of PKC-θ in TCR-induced activation of ERK endows PKC-θ a critical molecule in the positive selection as well as in the activation of mature T cells (<xref ref-type="bibr" rid="bib2">Altman and Kong, 2016</xref>; <xref ref-type="bibr" rid="bib51">Morley et al., 2008</xref>). Consistently, we also observed the defect of TCR-induced ERK activation caused by PKC-θ deficiency cannot be compensated in thymocytes (<xref ref-type="fig" rid="fig3">Figure 3F,J</xref>). Therefore, PKC-θ is essential for TCR-induced ERK activation both in mature and immature T cells. Due to the important roles of ERK signal in both αβ T and γδ T-cell development (<xref ref-type="bibr" rid="bib11">Ciofani and Zúñiga-Pflücker, 2010</xref>; <xref ref-type="bibr" rid="bib15">Delgado et al., 2000</xref>; <xref ref-type="bibr" rid="bib17">Fischer et al., 2005</xref>; <xref ref-type="bibr" rid="bib49">McNeil et al., 2005</xref>), it will be interesting to further investigate the role of PKC-θ in γδ T cells development.</p><p>Upon TCR stimulation, PKC-θ also translocates to the nucleus, where it associates with chromatin and forms transcription complexes with Pol II, MSK-1, LSD1, and 14-3-3ζ (<xref ref-type="bibr" rid="bib63">Sutcliffe et al., 2011</xref>) or phosphorylates a key splicing factor, SC35, and histone (<xref ref-type="bibr" rid="bib36">Li et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">McCuaig et al., 2015</xref>) to activate downstream gene transcription. Here, we show that sumoylated PKC-θ translocates to the NE to promote the function of the NPC. Interestingly, while the nuclear localization sequence of PKC-θ is known to mediate its nuclear localization (<xref ref-type="bibr" rid="bib64">Sutcliffe et al., 2012</xref>), desumoylation of PKC-θ or inactivation of its catalytic activity prevented its NE localization (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Thus, different mechanisms may be involved in PKC-θ translocation to the NE vs. the nucleus. It is, therefore, possible that localization of PKC-θ to the NE promotes the function of NPC, which, in turn, would enable the nuclear translocation of cargo PKC-θ. We have previously demonstrated that PKC-θ sumoylation, catalyzed by the SUMO E3 ligase PIASxβ, is required for its central IS localization (<xref ref-type="bibr" rid="bib74">Wang et al., 2015</xref>). It remains to be determined whether PKC-θ translocation to the NE similarly requires or is dependent on another mechanism.</p><p>The RanBP2 subcomplex is a multifunctional component of NPC in the animal kingdom (<xref ref-type="bibr" rid="bib23">Hampoelz et al., 2019a</xref>; <xref ref-type="bibr" rid="bib38">Lin and Hoelz, 2019</xref>). In addition to its roles in nuclear transport and NPC assembly (<xref ref-type="bibr" rid="bib27">Hutten et al., 2008</xref>), the RanBP2 subcomplex has other cellular functions, including translational control (<xref ref-type="bibr" rid="bib40">Mahadevan et al., 2013</xref>) and nuclear import of pathogens (<xref ref-type="bibr" rid="bib16">Dharan et al., 2016</xref>). Moreover, the RanBP2/RanGAP1-SUMO1/Ubc9 complex is a multi-subunit SUMO E3 ligase (<xref ref-type="bibr" rid="bib54">Reverter and Lima, 2005</xref>; <xref ref-type="bibr" rid="bib75">Werner et al., 2012</xref>) that mediates the sumoylation of the GTPase Ran (<xref ref-type="bibr" rid="bib27">Hutten et al., 2008</xref>; <xref ref-type="bibr" rid="bib58">Sakin et al., 2015</xref>; <xref ref-type="bibr" rid="bib72">Wälde et al., 2012</xref>) and the sumoylation of topoisomerase IIa and borealin to regulate mitosis (<xref ref-type="bibr" rid="bib14">Dawlaty et al., 2008</xref>; <xref ref-type="bibr" rid="bib30">Klein et al., 2009</xref>). Therefore, our current findings that reveal a TCR-PKC-θ-RanGAP1 signaling axis not only exposes a novel regulatory layer of TCR signaling, but also provides a new angle to understand fundamental mechanisms of T-cell immunity.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or <break/>resource</th><th valign="top">Designation</th><th valign="top">Source or <break/>reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Strain, strain background <break/>(<italic>Mus musculus</italic>)</td><td valign="top">C57BL/6 <break/>(<italic>Prkcq<sup>−/<italic>−</italic></sup></italic>)</td><td valign="top">A gift from D. Littman (<xref ref-type="bibr" rid="bib74">Wang et al., 2015</xref>)</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26390157/">26390157</ext-link></td><td valign="top"/></tr><tr><td valign="top">Cell line (<italic>Homo-sapiens</italic>)</td><td valign="top">Jurkat, Clone E6-1</td><td valign="top">ATCC</td><td valign="top">TIB-152</td><td valign="top"/></tr><tr><td valign="top">Cell line (<italic>Homo-sapiens</italic>)</td><td valign="top">Jurkat-TAg</td><td valign="top">Cellosaurus</td><td valign="top">CVCL_C831 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_C831">CVCL_C831</ext-link></td><td valign="top"/></tr><tr><td valign="top">Antibody</td><td valign="top">Goat polyclonal anti-PKC-θ</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat #: sc-1875, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_675806">AB_675806</ext-link></td><td valign="top">IF (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-RanGAP1</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat #: sc-28322, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2176987">AB_2176987</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-importin β1</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat #: sc-137016, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2133993">AB_2133993</ext-link></td><td valign="top">WB (1:1000) <break/>IF (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti- Ran</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat #: sc-271376, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10610890">AB_10610890</ext-link></td><td valign="top">WB (1:1000) <break/>IF (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti- RanBP2</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat #: sc-74518, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2176784">AB_2176784</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti- Ubc9</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat #: sc-271057, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10610674">AB_10610674</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti- NF-ATc1</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat #: sc-7294, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2152503">AB_2152503</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-c-Myc</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat #: sc-40, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2857941">AB_2857941</ext-link></td><td valign="top">WB (1:1000) <break/>IF (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti- actin</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat #: sc-8432, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_626630">AB_626630</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-p-Ser/Phosphoserine</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat #: sc-81516, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1128626">AB_1128626</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat polyclonal anti-Lamin B1</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat #: sc-30264, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2136305">AB_2136305</ext-link></td><td valign="top">WB (1:1000) <break/>IF (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-p65(NF-κB)</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat #: sc-109, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_632039">AB_632039</ext-link></td><td valign="top">WB (1:1000) <break/>IF (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-Histone 1</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat #: sc-8030, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_675641">AB_675641</ext-link></td><td valign="top">WB (1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-c-Jun</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat #: 9165, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2130165">AB_2130165</ext-link></td><td valign="top">WB (1:1000) <break/>IF (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-Dis3</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat #: sc-398663</td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-c-Fos</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat #: 2250, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2247211">AB_2247211</ext-link></td><td valign="top">WB (1:1000) <break/>IF (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-phospho-Ser/Thr</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat #: 9631, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_330308">AB_330308</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-phospho-ERK1/2</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat #: 9106, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_331768">AB_331768</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-Na/K-ATPas</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat #: 3010, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2060983">AB_2060983</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-GAPDH</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat #: 2118, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_561053">AB_561053</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-CRM1</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat #: 46249, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2799298">AB_2799298</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-Histone 2B</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat #: 12364, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2714167">AB_2714167</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-Histone 3</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat #: 4499, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10544537">AB_10544537</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-NF-ATc1</td><td valign="top">Abcam</td><td valign="top">Cat #: ab25916, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_448901">AB_448901</ext-link></td><td valign="top">IF (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-RanGAP1</td><td valign="top">Abcam</td><td valign="top">Cat #: ab92360, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10564003">AB_10564003</ext-link></td><td valign="top">IF (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal anti-RPL26</td><td valign="top">Abcam</td><td valign="top">Cat #: ab59567, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_945306">AB_945306</ext-link></td><td valign="top">WB (1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-RPS3</td><td valign="top">Abcam</td><td valign="top">Cat #: ab181992</td><td valign="top">WB (1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-NXF1</td><td valign="top">Abcam</td><td valign="top">Cat #: ab129160, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_11142853">AB_11142853</ext-link></td><td valign="top">WB (1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti- Mab414</td><td valign="top">BioLegend</td><td valign="top">Cat #: 902901, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2565026">AB_2565026</ext-link></td><td valign="top">WB (1:1000) <break/>IF (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rat monoclonal anti-mouse CD3</td><td valign="top">BioLegend</td><td valign="top">Cat #: 100202, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312659">AB_312659</ext-link></td><td valign="top">5 μg/ml</td></tr><tr><td valign="top">Antibody</td><td valign="top">Syrian Hamster monoclonal anti-mouse CD28</td><td valign="top">BioLegend</td><td valign="top">Cat #: 102102, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312867">AB_312867</ext-link></td><td valign="top">2 μg/ml</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-Human CD3(OKT3)</td><td valign="top">BioLegend</td><td valign="top">Cat #: 317302, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_571927">AB_571927</ext-link></td><td valign="top">5 μg/ml</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-Human CD28(CD28.2)</td><td valign="top">BioLegend</td><td valign="top">Cat #: 302902, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_314304">AB_314304</ext-link></td><td valign="top">2 μg/ml</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 488-coupled chicken anti-mouse IgG</td><td valign="top">Invitrogen</td><td valign="top">Cat #: A-21200, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535786">AB_2535786</ext-link></td><td valign="top">IF (1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 594-coupled chicken anti-mouse IgG</td><td valign="top">Invitrogen</td><td valign="top">Cat #: A-21201, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_141630">AB_141630</ext-link></td><td valign="top">IF (1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 594-coupled chicken anti-rabbit IgG</td><td valign="top">Invitrogen</td><td valign="top">Cat #: A-21442, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_141840">AB_141840</ext-link></td><td valign="top">IF (1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 488-coupled donkey anti-goat IgG</td><td valign="top">Invitrogen</td><td valign="top">Cat #: A-11055, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2534102">AB_2534102</ext-link></td><td valign="top">IF (1:2000)</td></tr><tr><td valign="top">Other</td><td valign="top">Cell Tracker Blue</td><td valign="top">Invitrogen</td><td valign="top">Cat #: C2110</td><td valign="top">IF: 10 μM</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pcDNA3.1( ) <break/>(plasmid)</td><td valign="top">Invitrogen</td><td valign="top">Cat #: V79020</td><td valign="top"/></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pGEX-4T-2</td><td valign="top">GE</td><td valign="top">Cat #: 27-4581-01</td><td valign="top"/></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pFlag-CMV2</td><td valign="top">Sigma</td><td valign="top">Cat #: E7396</td><td valign="top"/></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pMXs-IRES-GFP Retroviral Vector</td><td valign="top">Cell Biolabs</td><td valign="top">Cat #: RTV-013</td><td valign="top"/></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">LentiCRISPRv2</td><td valign="top">Addgene</td><td valign="top">Cat #: 52961</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RanGAP1-F</td><td valign="top">NM_001278651.2</td><td valign="top">CGGGATCCATGGCCTCGGAAGACATTGCCAAGC</td><td valign="top">Primer for PCR</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RanGAP1-R</td><td valign="top">NM_001278651.2</td><td valign="top">ATAAGAATGCGGCCGCCTAGACCTTGTACAGCGTCTGCAGC</td><td valign="top">Primer for PCR</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RanGAP1-S34A-F</td><td valign="top">NM_001278651.2</td><td valign="top">CAAGAGCCTCAAACTCAACGCCGCAGAAGATGCTAAAGATG</td><td valign="top">Primer for PCR</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RanGAP1-T419A-F</td><td valign="top">NM_001278651.2</td><td valign="top">CTGGACCCTAACGCCGGGGAGCCAGCTC</td><td valign="top">Primer for PCR</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RanGAP1-S478A-F</td><td valign="top">NM_001278651.2</td><td valign="top">CCTTCCTAAAGGTGTCAGCCGTGTTCAAGGACGAAG</td><td valign="top">Primer for PCR</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RanGAP1-S504A-F</td><td valign="top">NM_001278651.2</td><td valign="top">GAAGGCTTTCAACGCCTCGTCCTTCAAC</td><td valign="top">Primer for PCR</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RanGAP1-S506A-F</td><td valign="top">NM_001278651.2</td><td valign="top">CTTTCAACTCCTCGGCCTTCAACTCCAAC</td><td valign="top">Primer for PCR</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RanGAP1-S504A/S506A-F</td><td valign="top">NM_001278651.2</td><td valign="top">CTGATGCAGAAGGCTTTCAACGCCAGCGCCTTCAA <break/>CTCCAACACCTTCC</td><td valign="top">Primer for PCR</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RanGAP1-S504E/S506E-F</td><td valign="top">NM_001278651.2</td><td valign="top">CTGATGCAGAAGGCTTTCAACGAGAGCGAGTTCAAC <break/>TCCAACACCTTCC</td><td valign="top">Primer for PCR</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RanGAP1-K524R-F</td><td valign="top">NM_001278651.2</td><td valign="top">CATGGGTCTGCTCAGGAGTGAAGACAAG</td><td valign="top">Primer for PCR</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RanGAP1 sgRNA</td><td valign="top">NM_001278651.2</td><td valign="top">CACCGCAGAGGGAGTGCCACT</td><td valign="top">CRISPR-Cas9 guides</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">shPKC-θ</td><td valign="top">NM_006257.5</td><td valign="top">GAGTATGTCGAATCAGAGA</td><td valign="top">dsRNA for RNAi</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">siPKC-θ</td><td valign="top">Previous study in lab (<xref ref-type="bibr" rid="bib74">Wang et al., 2015</xref>)</td><td valign="top">GCUUGUAACUUGAGAUCUA</td><td valign="top">dsRNA for RNAi</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">siRanGAP1-1</td><td valign="top">NM_001278651.2</td><td valign="top">GGAGUGUUGACAACCCAAA</td><td valign="top">dsRNA for RNAi</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">siRanGAP1-2</td><td valign="top">NM_001278651.2</td><td valign="top">GUGAGCUGCUCCGCCAUUAAA</td><td valign="top">dsRNA for RNAi</td></tr><tr><td valign="top">Software algorithm</td><td valign="top">Fiji/Image-J</td><td valign="top">MPI-CBG, Dresden/ <break/>National Institutes of Health (NIH)</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22743772/">22743772</ext-link> <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002285">SCR_002285</ext-link></td><td valign="top">Image processing and analysis</td></tr><tr><td valign="top">Software algorithm</td><td valign="top">Graphpad Prism v6</td><td valign="top">Graphpad</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link></td><td valign="top">Graphs and statistical analysis</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>C57BL/6 (B6) and <italic>Prkcq<sup>−/−</sup></italic> mice (a gift from D. Littman) were housed under specific pathogen-free conditions and were manipulated according to the guidelines approved by the Animal Care and Ethics committee of Sun Yat-Sen University.</p></sec><sec id="s4-2"><title>Plasmids</title><p>The cDNAs encoding RanGAP1, p65/NF-κB, NF-ATc1, c-Jun, c-Fos were amplified by PCR from a Jurkat E6.1 T-cell cDNA library and were cloned into the vectors pcDNA3.1-HA (Invitrogen), pGEX-4T-2 (Sigma), or pcDNA3.1-GFP (Invitrogen). Plasmids encoding HA-tagged SUMO1, and c-Myc-tagged PKC-θ, PKC-θ−2KR, PKC-θ-K409R, PKC-θ-A148E have been described (<xref ref-type="bibr" rid="bib74">Wang et al., 2015</xref>). Specific point mutations of RanGAP1 were introduced by site-directed mutagenesis with a QuikChange Site-Directed Mutagenesis Kit (Stratagene).</p></sec><sec id="s4-3"><title>Human primary T cells</title><p>Buffy coat cells from de-identified healthy human peripheral blood was provided by the Guangzhou blood center; it was handled according to the guidelines of the Ethics committee of Sun Yat-Sen University. Peripheral blood mononuclear cell isolation and T-cell enrichment were performed as previously described (<xref ref-type="bibr" rid="bib74">Wang et al., 2015</xref>).</p></sec><sec id="s4-4"><title>Cell culture, transfection, and stimulation</title><p>Spleens and thymi of <italic>Prkcq<sup>−/−</sup></italic> mice were dissociated into single-cell suspensions in PBS containing 1% FBS (Gibco), and samples were depleted of red blood cells with RBC lysis buffer (Sigma). Mouse splenic T cells were isolated with a Pan T Cell Isolation Kit II (Miltenyi Biotec). Jurkat T cells and Raji B cells were cultured in complete RPMI-1640 (Hyclone, Logan, UT) medium supplemented with 10% FBS, and 100 U/ml each of penicillin and streptomycin (Life Technologies). Jurkat E6.1 T cells stably expressing PKC-θ-specific short hairpin RNA (shPKC-θ) were grown in the presence of aminoglycoside G418 (700 μg/ml; Invitrogen). Cell lines were electro-transfected with various vectors using the Cell Line Nucleofector Kit (Lonza, Germany), and human primary T cells were transfected with various vectors using the P3 Primary Cell 4D-Nucleofector Kit (Lonza). For APC stimulation of T cells, Raji B lymphoma cells were incubated for 30 min at 37°C in the presence or absence of SEE (100 ng/ml; Toxin Technology). The cells were washed with PBS and were mixed with Jurkat T cells at a ratio of 1:1, followed by incubation for various times at 37°C. For antibody stimulation, mouse or human T cells were stimulated for various times with anti-CD3 (5 μg/ml) and/or anti-CD28 (2 μg/ml), which were crosslinked with goat anti-mouse IgG (10 μg/ml). Cell lines were authenticated using short tandem repeat profiling at GENEWIZ, Inc (Suzhou, China). Mycoplasma test for cell culture was done in a monthly basis using PCR Mycoplasma Detection Kit (abm, G238). Cells used in experiments were within 10 passages from thawing.</p></sec><sec id="s4-5"><title>IP and immunoblotting</title><p>Cells washed with ice-cold PBS and lysed in lysis buffer (20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% Nonidet-P-40, 5 mM NaPPi, 1 mM sodium orthovanadate [Na<sub>3</sub>VO<sub>4</sub>], 1 mM PMSF, and 10 μg/ml each aprotinin and leupeptin). Whole-cell lysates were incubated overnight at 4°C with the indicated antibodies, and proteins were collected on protein G-Sepharose beads (GE Healthcare) for an additional 4 hr at 4°C with gentle shaking. The immunoprecipitated proteins were resolved by SDS–PAGE, transferred onto PVDF membranes, and probed with primary antibodies. Signals were visualized by enhanced chemiluminescence (YESEN, Shanghai, CHINA) and films were exposed in the ChemiDoc XRS system (Bio-Rad) or to X-ray film. Densitometry analysis was performed with ImageJ software.</p></sec><sec id="s4-6"><title>PM, NE, and NPC fractionation</title><p>For the PM purification (<xref ref-type="fig" rid="fig1">Figure 1A,B</xref>), cells washed with ice-cold PBS were resuspended in an ice-cold hypotonic buffer (10 mM HEPES, pH 7.4, 42 mM KCl, 5 mM MgCl<sub>2</sub>, 1 mM DTT, and protease inhibitors [leupeptin, PMSF, and aprotinin]) for 20 min on ice. The cell suspension was pushed 10 times through a 30-gauge needle, followed by centrifugation at 200 × g for 10 min. The pellet as was used as the nuclear fraction. The supernatant was centrifugation at 25,000 × g for 1 hr, and the pellet was used as the PM.</p><p>The nuclear and NE fractions were prepared using the NE-PERTM Nuclear and Cytoplasmic Extraction kit (Thermo Scientific) as per manufacturer’s instructions. Briefly, cells washed with ice-cold PBS were resuspended in Cytoplasmic Extraction Reagents containing proteinase inhibitors, vortexed vigorously, and centrifuged at 16,000 × g for 10 min. The pellet was resuspended in Nuclear Extraction Reagent containing proteinase inhibitors, vortexed vigorously, and centrifuged at 16,000 × g for 10 additional min. The supernatant and the insoluble fraction, representing the nuclear extract and NE, respectively, were collected.</p><p>The NPC fraction was prepared as described (<xref ref-type="bibr" rid="bib28">Jafferali et al., 2014</xref>), with minor modifications. Cells were washed with PBS and treated with 1 mM dithiobis (succinimidyl propionate) (Sangon Biotech) in RPMI-1640 medium for 15 min at room temperature to crosslink the NPC. The reaction was stopped by adding 15 mM Tris–HCl (pH 7.4) for 10 min at room temperature. Nuclei were pelleted as described above, followed by incubation in 5 volumes of 7 M urea containing 1% Triton X-100 (TX-100) and protease inhibitors for 20 min on ice to resuspend the nuclei pellet. The suspension was collected as the NPC fraction, diluted eightfold in PBS containing protease inhibitors, sonicated on ice, and cleared by centrifugation at 1000 × g for 10 min.</p></sec><sec id="s4-7"><title>Fluorescence microscopy and analysis</title><p>Immunofluorescence was conducted as previously described (<xref ref-type="bibr" rid="bib74">Wang et al., 2015</xref>). Briefly, conjugates of Jurkat T cells and Raji APCs were plated on poly-<sc>l</sc>-lysine-coated slides, incubated for 15 min at room temperature, fixed for 15 min with 4% PFA, and permeabilized with 0.2% Triton X-100 for 10 min at room temperature. The slides were blocked with 2% BSA for 1 hr, and samples were stained with indicated antibodies overnight at 4°C. After washing with PBS, slides incubated for 1 hr at room temperature with secondary antibodies. After three washes with PBS, the cells were mounted with a drop of mounting medium. Images were obtained with a Leica SP5 laser-scanning confocal microscope equipped with 100× objective lens with laser excitation at 405 nm, 488 nm, 561 nm, or 633 nm. Each image is a single z-section, and the z-position closest to the center of the cell (the equatorial plane) was chosen. Images were analyzed and processed with ImageJ and Adobe Photoshop CS6 software. Briefly, quantitative colocalization analysis of confocal microscopy images was performed with the JACoP module of the FIJI-ImageJ software (<ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/index.html">https://imagej.nih.gov/ij/index.html</ext-link>) to generate the Pearson’s correlation coefficient (PCC) with a range of 1 (perfect correlation) to −1 (perfect exclusion). PCC measures the pixel-by-pixel covariance in the signal levels of two channels of an image. The protein nuclear/cytoplasmic (N/C) expression ratio of confocal microscope images was quantified as follows: N/C = Total fluorescence intensity in nuclear area/(Total fluorescence intensity in whole-cell area – total fluorescence intensity in nucleus). The fluorescence intensities of PKC-θ or RanGAP1 in the NE were quantified with FIJI-ImageJ software. The region of NE was automatically segmented as described with FIJI-ImageJ software (<xref ref-type="bibr" rid="bib69">Tosi et al., 2020</xref>).</p></sec><sec id="s4-8"><title>Expression and purification of GST-fusion proteins</title><p>GST-fusion proteins were expressed in <italic>E. coli</italic> BL21 after induction with 0.3 mM isopropyl-beta-<sc>d</sc>-thiogalactopyranoside (Sangon Biotech) for 12 hr at 18°C. Bacteria were resuspended in lysis buffer (1× PBS: 137 mM NaCl, 2.7 mM KCl, 10 mM Na<sub>2</sub>HPO<sub>4</sub>, and 1.8 mM KH<sub>2</sub>PO<sub>4</sub>, pH 7.4; proteinase inhibitors, and 1% Triton X-100 for GST-Nups or 0.1% Triton X-100 for GST-RanGAP1). Bacterial extracts were sonicated for 10 min and centrifuged. GST-fusion proteins were purified by incubation with glutathione-Sepharose beads (GE Healthcare). The precipitates were washed 3× with lysis buffer, then eluted with elution buffer (50 mM Tris–HCL, pH 8.0, 15 mM reduced glutathione). Coomassie Brilliant Blue staining was used as loading control.</p></sec><sec id="s4-9"><title>PKC-θ in vitro kinase assay</title><p>The kinase assay was conducted as previously described (<xref ref-type="bibr" rid="bib74">Wang et al., 2015</xref>). Jurkat T-cell lysates were immunoprecipitated with anti-PKC-θ or a control IgG. The IPs were washed 5× with RIPA buffer containing 0.2% SDS and 1× with PKC-θ kinase buffer (20 mM HEPES, pH 7.2–7.4, 10 mM MgCl<sub>2</sub>, and 0.1 mM EGTA) and were resuspended in 25 μl of kinase buffer containing 20 μM cold ATP, 10 μM PMA, 200 μg/ml phosphatidyserine, and 1 μg of recombinant GST-RanGAP1 protein or GST-RanGAP1 mutant proteins as substrate. After incubation for 30 min at 30°C with gentle shaking, the reaction was stopped by adding 5× loading buffer. Samples were boiled at 95°C for 10 min, separated by SDS–PAGE, and detected by western blot with an anti-p-Ser/Thr antibody (a mixture of phospho-Ser- and phospho-Thr-specific antibodies, BD Biosciences, 9631).</p></sec><sec id="s4-10"><title>Mass spectrometric analysis</title><p>Samples for co-IP were prepared as described previously with minor modification (<xref ref-type="bibr" rid="bib74">Wang et al., 2015</xref>). In brief, anti-CD3/CD28-stimulated Jurkat T cells were lysed and followed by IP with anti-PKC-θ or anti-IgG. IPs immobilized on protein G beads and 1 μg recombinant GST-RanGAP1 protein immobilized on GSH Sepharose beads were separately washed 2× with kinase buffer and mixed to initiate the kinase assay. Reactions were terminated by Laemmli sample buffer, boiled, and resolved on SDS–PAGE. Gel bands of interest were excised and subjected to tryptic digestion. After desalting, the peptides were analyzed by tandem MS. A splitless Ultra 2D Plus system (Eksigent) coupled to the TripleTOF 5600 System (AB SCIEX) with a Nanospray III source (AB SCIEX) were performed to analyze immunoprecipitated proteins and identify posttranscriptional modification sites of RanGAP1. The search engine ProteinPilot V4.5 was used to assigned potential modification sites with high confidence.</p></sec><sec id="s4-11"><title>Immunoelectron microscopy</title><p>Immunoelectron microscopy was performed on Jurkat T cells stimulated for 0–15 min with anti-CD3 plus anti-CD28. Cells were fixed in buffer (4% paraformaldehyde, 0.2% glutaraldehyde), pelleted, treated with LR white acrylic resin (L9774, Sigma-Aldrich), and then frozen for 72 hr at −20°C with UV irradiation. Frozen pellets were sectioned by a cryo-ultramicrotome (EM UC6 and FC6, Leica). Cryosections were thawed, rinsed in PBS with 1% glycine, and incubated in 0.01 M PBS containing 0.1% BSA and 5% goat serum for 30 min at room temperature. The samples were incubated with mouse anti-PKC-θ antibody diluted 1:50 overnight at 4°C, and rinsed in 0.01 M PBS, then incubated with 10 nm colloidal gold-labeled anti-mouse IgG secondary antibody (G7652, Sigma-Aldrich) diluted 1:25 for 3 hr at room temperature. Grids were then rinsed in 0.01 M PBS and ultrapure water and embedded in 2% uranyl acetate with lead citrate. Images were taken on an electron microscope (JEM1400, JEOL).</p></sec><sec id="s4-12"><title>Enzyme-linked immunosorbent assay</title><p>Samples for enzyme-linked immunosorbent assay (ELISA) were prepared as described previously (<xref ref-type="bibr" rid="bib74">Wang et al., 2015</xref>). Aliquots of T cells (3 × 10<sup>6</sup>) transfected with HA-RanGAP1 or HA-RanGAP1<sup>AA</sup> vectors were stimulated for 24 hr with anti-CD3 plus anti-CD28, and the concentration of IL-2 in culture supernatants was determined by ELISA according to the manufacturer’s instructions (BD Biosciences).</p></sec><sec id="s4-13"><title>CRISPR/Cas9 gene editing</title><p>LentiCRISPRv2 which contains Cas9 and GFP was used to edit a RanGAP1 genomic fragment in the Jurkat E6.1 cell line. The gRNA targeting sequences are listed in the Key resources table. Cells in a logarithmic growth phase were transfected with plasmids encoding gRNA by nucleofection (Lonza 4D Nucleofector system). Forty-eight hours after transfection, GFP-positive cells were sorted on a flow cytometer (BD FACSAria II) and seeded individually into 96-well plates. The RanGAP1genome-edited cell line was identified by genomic DNA sequencing.</p></sec><sec id="s4-14"><title>Retrovirus transduction</title><p>Platinum-E packaging cells were plated in a six-well plate in 2 ml RPMI-1640 medium plus 10% FBS. After 24 hr, cells were transfected with empty pMX vector or RanGAP1 (AA or EE)-expressing vector DNA (5 μg) with Lipofectamine 3000 Reagent (Thermo Fisher Scientific). After an overnight incubation, the medium was replaced and cultures were maintained for another 24 hr. Retroviral supernatants were then collected and filtered, supplemented with 5 μg/ml of polybrene and 100 U/ml of recombinant IL-2, and then used to infect T cells that had been pre-activated for 48 hr with plate-bound monoclonal anti-CD3 antibody (5 μg/ml) and soluble anti-CD28 monoclonal antibody (2.5 μg/ml) in the presence of recombinant IL-2 (100 U/ml). Plates were centrifuged for 1 hr at 2000 r.p.m. and incubated for 4 hr at 32°C and overnight at 37°C, followed by one additional retroviral transduction the next day. On day 4, cells were washed and cultured in RPMI-1640 medium containing 10% (vol/vol) FBS and recombinant IL-2 (100 U/ml) for another 3 days before re-stimulation with monoclonal anti-CD3 plus –CD28 antibodies.</p></sec><sec id="s4-15"><title>Computational analysis</title><p>I-Mutant2.0 (<ext-link ext-link-type="uri" xlink:href="http://folding.biofold.org/i-mutant/i-mutant2.0.html">folding.biofold.org/i-mutant/i-mutant2.0.html</ext-link>) was using to predict RanGAP1 protein stability changes with single point mutation from the protein sequence (NP_002874.1).</p></sec><sec id="s4-16"><title>Statistical analysis</title><p>Prism (GraphPad 6.0 Software) was used for graphs and statistical analysis. Statistical analysis was performed with a two-tailed, unpaired Student’s t-test or one-way ANOVA with post hoc test. p-values of less than 0.05 were considered statistically significant. Graphs represent mean ± standard error of the mean (s.e.m).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>Supported by the National Natural Science Foundation of China (31670893, 31370886, 31170846), the Guangzhou Science and Technology Project (201904010445), Guangdong Provincial Natural Science Foundation (2021A1515010543), and Guangdong Science and Technology Department (2020B1212060031). We thank Dr. G Fu for helpful discussion and Dr. M Zhao for help in PBMC-related experiment.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Investigation</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Validation, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Validation, Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Investigation</p></fn><fn fn-type="con" id="con8"><p>Investigation</p></fn><fn fn-type="con" id="con9"><p>Investigation</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the Sun Yat-Sen University. All of the animals were handled according to guidelines approved by the Animal Care and Ethics committee of Sun Yat-Sen University. The protocol was approved by the Committee on the Ethics of Animal Experiments of Sun Yat-Sen University (Permit Number: SYSU-IACUC-2019-B616). The mice were euthanatized by CO2 from compressed gas cylinders, and we complied with all the ethical regulation.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-67123-transrepform-v3.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname> <given-names>RT</given-names></name><name><surname>Weiss</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Jurkat T cells and development of the T-cell receptor signalling paradigm</article-title><source>Nature Reviews Immunology</source><volume>4</volume><fpage>301</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1038/nri1330</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altman</surname> <given-names>A</given-names></name><name><surname>Kong</surname> <given-names>K-F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Protein Kinase C Enzymes in the Hematopoietic and Immune Systems</article-title><source>Annual Review of Immunology</source><volume>34</volume><fpage>511</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-041015-055347</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atsaves</surname> <given-names>V</given-names></name><name><surname>Leventaki</surname> <given-names>V</given-names></name><name><surname>Rassidakis</surname> <given-names>GZ</given-names></name><name><surname>Claret</surname> <given-names>FX</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>AP-1 transcription factors as regulators of immune responses in Cancer</article-title><source>Cancers</source><volume>11</volume><elocation-id>1037</elocation-id><pub-id pub-id-type="doi">10.3390/cancers11071037</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baier</surname> <given-names>G</given-names></name><name><surname>Telford</surname> <given-names>D</given-names></name><name><surname>Giampa</surname> <given-names>L</given-names></name><name><surname>Coggeshall</surname> <given-names>KM</given-names></name><name><surname>Baier-Bitterlich</surname> <given-names>G</given-names></name><name><surname>Isakov</surname> <given-names>N</given-names></name><name><surname>Altman</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Molecular cloning and characterization of PKC theta, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells</article-title><source>Journal of Biological Chemistry</source><volume>268</volume><fpage>4997</fpage><lpage>5004</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)53494-3</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baier-Bitterlich</surname> <given-names>G</given-names></name><name><surname>Uberall</surname> <given-names>F</given-names></name><name><surname>Bauer</surname> <given-names>B</given-names></name><name><surname>Fresser</surname> <given-names>F</given-names></name><name><surname>Wachter</surname> <given-names>H</given-names></name><name><surname>Grunicke</surname> <given-names>H</given-names></name><name><surname>Utermann</surname> <given-names>G</given-names></name><name><surname>Altman</surname> <given-names>A</given-names></name><name><surname>Baier</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes</article-title><source>Molecular and Cellular Biology</source><volume>16</volume><fpage>1842</fpage><lpage>1850</lpage><pub-id pub-id-type="doi">10.1128/MCB.16.4.1842</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname> <given-names>M</given-names></name><name><surname>Hurt</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The nuclear pore complex: understanding its function through structural insight</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>18</volume><fpage>73</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1038/nrm.2016.147</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg-Brown</surname> <given-names>NN</given-names></name><name><surname>Gronski</surname> <given-names>MA</given-names></name><name><surname>Jones</surname> <given-names>RG</given-names></name><name><surname>Elford</surname> <given-names>AR</given-names></name><name><surname>Deenick</surname> <given-names>EK</given-names></name><name><surname>Odermatt</surname> <given-names>B</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name><name><surname>Ohashi</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>PKCθ Signals Activation versus Tolerance In Vivo</article-title><source>Journal of Experimental Medicine</source><volume>199</volume><fpage>743</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.1084/jem.20031022</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardes</surname> <given-names>NE</given-names></name><name><surname>Chook</surname> <given-names>YM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Nuclear import of histones</article-title><source>Biochemical Society Transactions</source><volume>48</volume><fpage>2753</fpage><lpage>2767</lpage><pub-id pub-id-type="doi">10.1042/BST20200572</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernier-Villamor</surname> <given-names>V</given-names></name><name><surname>Sampson</surname> <given-names>DA</given-names></name><name><surname>Matunis</surname> <given-names>MJ</given-names></name><name><surname>Lima</surname> <given-names>CD</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Structural Basis for E2-Mediated SUMO Conjugation Revealed by a Complex between Ubiquitin-Conjugating Enzyme Ubc9 and RanGAP1</article-title><source>Cell</source><volume>108</volume><fpage>345</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(02)00630-X</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borlido</surname> <given-names>J</given-names></name><name><surname>Sakuma</surname> <given-names>S</given-names></name><name><surname>Raices</surname> <given-names>M</given-names></name><name><surname>Carrette</surname> <given-names>F</given-names></name><name><surname>Tinoco</surname> <given-names>R</given-names></name><name><surname>Bradley</surname> <given-names>LM</given-names></name><name><surname>D’Angelo</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4+ T cell homeostasis</article-title><source>Nature Immunology</source><volume>19</volume><fpage>594</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0103-5</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciofani</surname> <given-names>M</given-names></name><name><surname>Zúñiga-Pflücker</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Determining γδ versus αß T cell development</article-title><source>Nature Reviews Immunology</source><volume>10</volume><fpage>657</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1038/nri2820</pub-id><pub-id pub-id-type="pmid">20725107</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collas</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Sequential PKC- and Cdc2-mediated phosphorylation events elicit zebrafish nuclear envelope disassembly</article-title><source>Journal of Cell Science</source><volume>112</volume><fpage>977</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1242/jcs.112.6.977</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coudronniere</surname> <given-names>N</given-names></name><name><surname>Villalba</surname> <given-names>M</given-names></name><name><surname>Englund</surname> <given-names>N</given-names></name><name><surname>Altman</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta</article-title><source>PNAS</source><volume>97</volume><fpage>3394</fpage><lpage>3399</lpage><pub-id pub-id-type="doi">10.1073/pnas.060028097</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawlaty</surname> <given-names>MM</given-names></name><name><surname>Malureanu</surname> <given-names>L</given-names></name><name><surname>Jeganathan</surname> <given-names>KB</given-names></name><name><surname>Kao</surname> <given-names>E</given-names></name><name><surname>Sustmann</surname> <given-names>C</given-names></name><name><surname>Tahk</surname> <given-names>S</given-names></name><name><surname>Shuai</surname> <given-names>K</given-names></name><name><surname>Grosschedl</surname> <given-names>R</given-names></name><name><surname>van Deursen</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Resolution of Sister Centromeres Requires RanBP2-Mediated SUMOylation of Topoisomerase IIα</article-title><source>Cell</source><volume>133</volume><fpage>103</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.01.045</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delgado</surname> <given-names>P</given-names></name><name><surname>Fernández</surname> <given-names>E</given-names></name><name><surname>Dave</surname> <given-names>V</given-names></name><name><surname>Kappes</surname> <given-names>D</given-names></name><name><surname>Alarcón</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>CD3δ couples T-cell receptor signalling to ERK activation and thymocyte positive selection</article-title><source>Nature</source><volume>406</volume><fpage>426</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1038/35019102</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dharan</surname> <given-names>A</given-names></name><name><surname>Talley</surname> <given-names>S</given-names></name><name><surname>Tripathi</surname> <given-names>A</given-names></name><name><surname>Mamede</surname> <given-names>JI</given-names></name><name><surname>Majetschak</surname> <given-names>M</given-names></name><name><surname>Hope</surname> <given-names>TJ</given-names></name><name><surname>Campbell</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>KIF5B and Nup358 Cooperatively Mediate the Nuclear Import of HIV-1 during Infection</article-title><source>PLOS Pathogens</source><volume>12</volume><elocation-id>e1005700</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005700</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>AM</given-names></name><name><surname>Katayama</surname> <given-names>CD</given-names></name><name><surname>Pagès</surname> <given-names>G</given-names></name><name><surname>Pouysségur</surname> <given-names>J</given-names></name><name><surname>Hedrick</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The Role of Erk1 and Erk2 in Multiple Stages of T Cell Development</article-title><source>Immunity</source><volume>23</volume><fpage>431</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2005.08.013</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forwood</surname> <given-names>JK</given-names></name><name><surname>Lam</surname> <given-names>MHC</given-names></name><name><surname>Jans</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Nuclear Import of Creb and AP-1 Transcription Factors Requires Importin-β1 and Ran but Is Independent of Importin-α</article-title><source>Biochemistry</source><volume>40</volume><fpage>5208</fpage><lpage>5217</lpage><pub-id pub-id-type="doi">10.1021/bi002732+</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>G</given-names></name><name><surname>Hu</surname> <given-names>J</given-names></name><name><surname>Niederberger-Magnenat</surname> <given-names>N</given-names></name><name><surname>Rybakin</surname> <given-names>V</given-names></name><name><surname>Casas</surname> <given-names>J</given-names></name><name><surname>Yachi</surname> <given-names>PP</given-names></name><name><surname>Feldstein</surname> <given-names>S</given-names></name><name><surname>Ma</surname> <given-names>B</given-names></name><name><surname>Hoerter</surname> <given-names>JAH</given-names></name><name><surname>Ampudia</surname> <given-names>J</given-names></name><name><surname>Rigaud</surname> <given-names>S</given-names></name><name><surname>Lambolez</surname> <given-names>F</given-names></name><name><surname>Gavin</surname> <given-names>AL</given-names></name><name><surname>Sauer</surname> <given-names>K</given-names></name><name><surname>Cheroutre</surname> <given-names>H</given-names></name><name><surname>Gascoigne</surname> <given-names>NRJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Protein Kinase C Is Required for T Cell Activation and Homeostatic Proliferation</article-title><source>Science Signaling</source><volume>4</volume><elocation-id>ra84</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2002058</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannoni</surname> <given-names>F</given-names></name><name><surname>Lyon</surname> <given-names>AB</given-names></name><name><surname>Wareing</surname> <given-names>MD</given-names></name><name><surname>Dias</surname> <given-names>PB</given-names></name><name><surname>Sarawar</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Protein Kinase C θ Is Not Essential for T-Cell-Mediated Clearance of Murine Gammaherpesvirus 68</article-title><source>Journal of Virology</source><volume>79</volume><fpage>6808</fpage><lpage>6813</lpage><pub-id pub-id-type="doi">10.1128/JVI.79.11.6808-6813.2005</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname> <given-names>Y</given-names></name><name><surname>Zebell</surname> <given-names>SG</given-names></name><name><surname>Liang</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Kang</surname> <given-names>B-H</given-names></name><name><surname>Dong</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Nuclear Pore Permeabilization Is a Convergent Signaling Event in Effector-Triggered Immunity</article-title><source>Cell</source><volume>166</volume><fpage>1526</fpage><lpage>1538</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.07.042</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamada</surname> <given-names>M</given-names></name><name><surname>Haeger</surname> <given-names>A</given-names></name><name><surname>Jeganathan</surname> <given-names>KB</given-names></name><name><surname>van Ree</surname> <given-names>JH</given-names></name><name><surname>Malureanu</surname> <given-names>L</given-names></name><name><surname>Wälde</surname> <given-names>S</given-names></name><name><surname>Joseph</surname> <given-names>J</given-names></name><name><surname>Kehlenbach</surname> <given-names>RH</given-names></name><name><surname>van Deursen</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Ran-dependent docking of importin-β to RanBP2/Nup358 filaments is essential for protein import and cell viability</article-title><source>Journal of Cell Biology</source><volume>194</volume><fpage>597</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1083/jcb.201102018</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hampoelz</surname> <given-names>B</given-names></name><name><surname>Andres-Pons</surname> <given-names>A</given-names></name><name><surname>Kastritis</surname> <given-names>P</given-names></name><name><surname>Beck</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>Structure and Assembly of the Nuclear Pore Complex</article-title><source>Annual Review of Biophysics</source><volume>48</volume><fpage>515</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1146/annurev-biophys-052118-115308</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hampoelz</surname> <given-names>B</given-names></name><name><surname>Schwarz</surname> <given-names>A</given-names></name><name><surname>Ronchi</surname> <given-names>P</given-names></name><name><surname>Bragulat-Teixidor</surname> <given-names>H</given-names></name><name><surname>Tischer</surname> <given-names>C</given-names></name><name><surname>Gaspar</surname> <given-names>I</given-names></name><name><surname>Ephrussi</surname> <given-names>A</given-names></name><name><surname>Schwab</surname> <given-names>Y</given-names></name><name><surname>Beck</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>Nuclear pores assemble from nucleoporin condensates during oogenesis</article-title><source>Cell</source><volume>179</volume><fpage>671</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.09.022</pub-id><pub-id pub-id-type="pmid">31626769</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hendriks</surname> <given-names>IA</given-names></name><name><surname>Lyon</surname> <given-names>D</given-names></name><name><surname>Young</surname> <given-names>C</given-names></name><name><surname>Jensen</surname> <given-names>LJ</given-names></name><name><surname>Vertegaal</surname> <given-names>ACO</given-names></name><name><surname>Nielsen</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>24</volume><fpage>325</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1038/nsmb.3366</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hietakangas</surname> <given-names>V</given-names></name><name><surname>Anckar</surname> <given-names>J</given-names></name><name><surname>Blomster</surname> <given-names>HA</given-names></name><name><surname>Fujimoto</surname> <given-names>M</given-names></name><name><surname>Palvimo</surname> <given-names>JJ</given-names></name><name><surname>Nakai</surname> <given-names>A</given-names></name><name><surname>Sistonen</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>PDSM, a motif for phosphorylation-dependent SUMO modification</article-title><source>PNAS</source><volume>103</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1073/pnas.0503698102</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutten</surname> <given-names>S</given-names></name><name><surname>Flotho</surname> <given-names>A</given-names></name><name><surname>Melchior</surname> <given-names>F</given-names></name><name><surname>Kehlenbach</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The Nup358-RanGAP Complex Is Required for Efficient Importin α/β-dependent Nuclear Import</article-title><source>Molecular Biology of the Cell</source><volume>19</volume><fpage>2300</fpage><lpage>2310</lpage><pub-id pub-id-type="doi">10.1091/mbc.e07-12-1279</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jafferali</surname> <given-names>MH</given-names></name><name><surname>Vijayaraghavan</surname> <given-names>B</given-names></name><name><surname>Figueroa</surname> <given-names>RA</given-names></name><name><surname>Crafoord</surname> <given-names>E</given-names></name><name><surname>Gudise</surname> <given-names>S</given-names></name><name><surname>Larsson</surname> <given-names>VJ</given-names></name><name><surname>Hallberg</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>MCLIP, an effective method to detect interactions of transmembrane proteins of the nuclear envelope in live cells</article-title><source>Biochimica et Biophysica Acta (BBA) - Biomembranes</source><volume>1838</volume><fpage>2399</fpage><lpage>2403</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2014.06.008</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joseph</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>S-T</given-names></name><name><surname>Jablonski</surname> <given-names>SA</given-names></name><name><surname>Yen</surname> <given-names>TJ</given-names></name><name><surname>Dasso</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The RanGAP1-RanBP2 Complex Is Essential for Microtubule-Kinetochore Interactions In Vivo</article-title><source>Current Biology</source><volume>14</volume><fpage>611</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2004.03.031</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname> <given-names>UR</given-names></name><name><surname>Haindl</surname> <given-names>M</given-names></name><name><surname>Nigg</surname> <given-names>EA</given-names></name><name><surname>Muller</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>RanBP2 and SENP3 Function in a Mitotic SUMO2/3 Conjugation-Deconjugation Cycle on Borealin</article-title><source>Molecular Biology of the Cell</source><volume>20</volume><fpage>410</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1091/mbc.e08-05-0511</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname> <given-names>K-F</given-names></name><name><surname>Yokosuka</surname> <given-names>T</given-names></name><name><surname>Canonigo-Balancio</surname> <given-names>AJ</given-names></name><name><surname>Isakov</surname> <given-names>N</given-names></name><name><surname>Saito</surname> <given-names>T</given-names></name><name><surname>Altman</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A motif in the V3 domain of the kinase PKC-θ determines its localization in the immunological synapse and functions in T cells via association with CD28</article-title><source>Nature Immunology</source><volume>12</volume><fpage>1105</fpage><lpage>1112</lpage><pub-id pub-id-type="doi">10.1038/ni.2120</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leach</surname> <given-names>KL</given-names></name><name><surname>Powers</surname> <given-names>EA</given-names></name><name><surname>Ruff</surname> <given-names>VA</given-names></name><name><surname>Jaken</surname> <given-names>S</given-names></name><name><surname>Kaufmann</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Type 3 protein kinase C localization to the nuclear envelope of phorbol ester-treated NIH 3T3 cells</article-title><source>Journal of Cell Biology</source><volume>109</volume><fpage>685</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1083/jcb.109.2.685</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>GW</given-names></name><name><surname>Melchior</surname> <given-names>F</given-names></name><name><surname>Matunis</surname> <given-names>MJ</given-names></name><name><surname>Mahajan</surname> <given-names>R</given-names></name><name><surname>Tian</surname> <given-names>Q</given-names></name><name><surname>Anderson</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Modification of Ran GTPase-activating Protein by the Small Ubiquitin-related Modifier SUMO-1 Requires Ubc9, an E2-type Ubiquitin-conjugating Enzyme Homologue</article-title><source>Journal of Biological Chemistry</source><volume>273</volume><fpage>6503</fpage><lpage>6507</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.11.6503</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>B</given-names></name><name><surname>Tournier</surname> <given-names>C</given-names></name><name><surname>Davis</surname> <given-names>RJ</given-names></name><name><surname>Flavell</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation</article-title><source>The EMBO Journal</source><volume>18</volume><fpage>420</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1093/emboj/18.2.420</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Hu</surname> <given-names>J</given-names></name><name><surname>Vita</surname> <given-names>R</given-names></name><name><surname>Sun</surname> <given-names>B</given-names></name><name><surname>Tabata</surname> <given-names>H</given-names></name><name><surname>Altman</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>SPAK kinase is a substrate and target of PKCθ in T-cell receptor-induced AP-1 activation pathway</article-title><source>The EMBO Journal</source><volume>23</volume><fpage>1112</fpage><lpage>1122</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600125</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Hardy</surname> <given-names>K</given-names></name><name><surname>Phetsouphanh</surname> <given-names>C</given-names></name><name><surname>Tu</surname> <given-names>WJ</given-names></name><name><surname>Sutcliffe</surname> <given-names>EL</given-names></name><name><surname>McCuaig</surname> <given-names>R</given-names></name><name><surname>Sutton</surname> <given-names>CR</given-names></name><name><surname>Zafar</surname> <given-names>A</given-names></name><name><surname>Munier</surname> <given-names>CM</given-names></name><name><surname>Zaunders</surname> <given-names>JJ</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Theodoratos</surname> <given-names>A</given-names></name><name><surname>Tan</surname> <given-names>A</given-names></name><name><surname>Lim</surname> <given-names>PS</given-names></name><name><surname>Knaute</surname> <given-names>T</given-names></name><name><surname>Masch</surname> <given-names>A</given-names></name><name><surname>Zerweck</surname> <given-names>J</given-names></name><name><surname>Brezar</surname> <given-names>V</given-names></name><name><surname>Milburn</surname> <given-names>PJ</given-names></name><name><surname>Dunn</surname> <given-names>J</given-names></name><name><surname>Casarotto</surname> <given-names>MG</given-names></name><name><surname>Turner</surname> <given-names>SJ</given-names></name><name><surname>Seddiki</surname> <given-names>N</given-names></name><name><surname>Kelleher</surname> <given-names>AD</given-names></name><name><surname>Rao</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Nuclear PKC-theta facilitates rapid transcriptional responses in human memory CD4 T cells through p65 and H2B phosphorylation</article-title><source>Journal of Cell Science</source><volume>129</volume><fpage>2448</fpage><lpage>2461</lpage><pub-id pub-id-type="doi">10.1242/jcs.181248</pub-id><pub-id pub-id-type="pmid">27149922</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>X</given-names></name><name><surname>O'Mahony</surname> <given-names>A</given-names></name><name><surname>Mu</surname> <given-names>Y</given-names></name><name><surname>Geleziunas</surname> <given-names>R</given-names></name><name><surname>Greene</surname> <given-names>WC</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Protein Kinase C-θ Participates in NF-κB Activation Induced by CD3-CD28 Costimulation through Selective Activation of IκB Kinase β</article-title><source>Molecular and Cellular Biology</source><volume>20</volume><fpage>2933</fpage><lpage>2940</lpage><pub-id pub-id-type="doi">10.1128/MCB.20.8.2933-2940.2000</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>DH</given-names></name><name><surname>Hoelz</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The Structure of the Nuclear Pore Complex (An Update)</article-title><source>Annual Review of Biochemistry</source><volume>88</volume><fpage>725</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-062917-011901</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Schneider</surname> <given-names>H</given-names></name><name><surname>Recino</surname> <given-names>A</given-names></name><name><surname>Richardson</surname> <given-names>C</given-names></name><name><surname>Goldberg</surname> <given-names>MW</given-names></name><name><surname>Rudd</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The Immune Adaptor SLP-76 Binds to SUMO-RANGAP1 at Nuclear Pore Complex Filaments to Regulate Nuclear Import of Transcription Factors in T Cells</article-title><source>Molecular Cell</source><volume>59</volume><fpage>840</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.07.015</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahadevan</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Akef</surname> <given-names>A</given-names></name><name><surname>Cui</surname> <given-names>XA</given-names></name><name><surname>Gueroussov</surname> <given-names>S</given-names></name><name><surname>Cenik</surname> <given-names>C</given-names></name><name><surname>Roth</surname> <given-names>FP</given-names></name><name><surname>Palazzo</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>RanBP2/Nup358 Potentiates the Translation of a Subset of mRNAs Encoding Secretory Proteins</article-title><source>PLOS Biology</source><volume>11</volume><elocation-id>e1001545</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001545</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahajan</surname> <given-names>R</given-names></name><name><surname>Delphin</surname> <given-names>C</given-names></name><name><surname>Guan</surname> <given-names>T</given-names></name><name><surname>Gerace</surname> <given-names>L</given-names></name><name><surname>Melchior</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>A Small Ubiquitin-Related Polypeptide Involved in Targeting RanGAP1 to Nuclear Pore Complex Protein RanBP2</article-title><source>Cell</source><volume>88</volume><fpage>97</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81862-0</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manicassamy</surname> <given-names>S</given-names></name><name><surname>Gupta</surname> <given-names>S</given-names></name><name><surname>Sun</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Selective function of PKC-theta in T cells</article-title><source>Cellular &amp; Molecular Immunology</source><volume>3</volume><fpage>263</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">16978534</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsland</surname> <given-names>BJ</given-names></name><name><surname>Soos</surname> <given-names>TJ</given-names></name><name><surname>Späth</surname> <given-names>G</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name><name><surname>Kopf</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Protein Kinase C θ Is Critical for the Development of In Vivo T Helper (Th)2 Cell But Not Th1 Cell Responses</article-title><source>Journal of Experimental Medicine</source><volume>200</volume><fpage>181</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1084/jem.20032229</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsland</surname> <given-names>BJ</given-names></name><name><surname>Nembrini</surname> <given-names>C</given-names></name><name><surname>Schmitz</surname> <given-names>N</given-names></name><name><surname>Abel</surname> <given-names>B</given-names></name><name><surname>Krautwald</surname> <given-names>S</given-names></name><name><surname>Bachmann</surname> <given-names>MF</given-names></name><name><surname>Kopf</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Innate signals compensate for the absence of PKC- during in vivo CD8+ T cell effector and memory responses</article-title><source>PNAS</source><volume>102</volume><fpage>14374</fpage><lpage>14379</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506250102</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsland</surname> <given-names>BJ</given-names></name><name><surname>Kopf</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>T-cell fate and function: PKC-θ and beyond</article-title><source>Trends in Immunology</source><volume>29</volume><fpage>179</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.it.2008.01.005</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matunis</surname> <given-names>MJ</given-names></name><name><surname>Coutavas</surname> <given-names>E</given-names></name><name><surname>Blobel</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex</article-title><source>Journal of Cell Biology</source><volume>135</volume><fpage>1457</fpage><lpage>1470</lpage><pub-id pub-id-type="doi">10.1083/jcb.135.6.1457</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matunis</surname> <given-names>MJ</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Blobel</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>SUMO-1 Modification and Its Role in Targeting the Ran GTPase-activating Protein, RanGAP1, to the Nuclear Pore Complex</article-title><source>Journal of Cell Biology</source><volume>140</volume><fpage>499</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1083/jcb.140.3.499</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCuaig</surname> <given-names>RD</given-names></name><name><surname>Dunn</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Masch</surname> <given-names>A</given-names></name><name><surname>Knaute</surname> <given-names>T</given-names></name><name><surname>Schutkowski</surname> <given-names>M</given-names></name><name><surname>Zerweck</surname> <given-names>J</given-names></name><name><surname>Rao</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>PKC-Theta is a Novel SC35 Splicing Factor Regulator in Response to T Cell Activation</article-title><source>Frontiers in Immunology</source><volume>6</volume><elocation-id>562</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2015.00562</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNeil</surname> <given-names>LK</given-names></name><name><surname>Starr</surname> <given-names>TK</given-names></name><name><surname>Hogquist</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A requirement for sustained ERK signaling during thymocyte positive selection in vivo</article-title><source>PNAS</source><volume>102</volume><fpage>13574</fpage><lpage>13579</lpage><pub-id pub-id-type="doi">10.1073/pnas.0505110102</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname> <given-names>T</given-names></name><name><surname>Begitt</surname> <given-names>A</given-names></name><name><surname>Lödige</surname> <given-names>I</given-names></name><name><surname>van Rossum</surname> <given-names>M</given-names></name><name><surname>Vinkemeier</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Constitutive and IFN-γ-induced nuclear import of STAT1 proceed through independent pathways</article-title><source>The EMBO Journal</source><volume>21</volume><fpage>344</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1093/emboj/21.3.344</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morley</surname> <given-names>SC</given-names></name><name><surname>Weber</surname> <given-names>KS</given-names></name><name><surname>Kao</surname> <given-names>H</given-names></name><name><surname>Allen</surname> <given-names>PM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Protein Kinase C-θ Is Required for Efficient Positive Selection</article-title><source>The Journal of Immunology</source><volume>181</volume><fpage>4696</fpage><lpage>4708</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.7.4696</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otsuka</surname> <given-names>S</given-names></name><name><surname>Ellenberg</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanisms of nuclear pore complex assembly – two different ways of building one molecular machine</article-title><source>FEBS Letters</source><volume>592</volume><fpage>475</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1002/1873-3468.12905</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeifhofer</surname> <given-names>C</given-names></name><name><surname>Kofler</surname> <given-names>K</given-names></name><name><surname>Gruber</surname> <given-names>T</given-names></name><name><surname>Ghaffari Tabrizi</surname> <given-names>N</given-names></name><name><surname>Lutz</surname> <given-names>C</given-names></name><name><surname>Maly</surname> <given-names>K</given-names></name><name><surname>Leitges</surname> <given-names>M</given-names></name><name><surname>Baier</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Protein Kinase C θ Affects Ca2+ Mobilization and NFAT Activation in Primary Mouse T Cells</article-title><source>Journal of Experimental Medicine</source><volume>197</volume><fpage>1525</fpage><lpage>1535</lpage><pub-id pub-id-type="doi">10.1084/jem.20020234</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reverter</surname> <given-names>D</given-names></name><name><surname>Lima</surname> <given-names>CD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Insights into E3 ligase activity revealed by a SUMO–RanGAP1–Ubc9–Nup358 complex</article-title><source>Nature</source><volume>435</volume><fpage>687</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1038/nature03588</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritterhoff</surname> <given-names>T</given-names></name><name><surname>Das</surname> <given-names>H</given-names></name><name><surname>Hofhaus</surname> <given-names>G</given-names></name><name><surname>Schröder</surname> <given-names>RR</given-names></name><name><surname>Flotho</surname> <given-names>A</given-names></name><name><surname>Melchior</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11482</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11482</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roose</surname> <given-names>JP</given-names></name><name><surname>Mollenauer</surname> <given-names>M</given-names></name><name><surname>Gupta</surname> <given-names>VA</given-names></name><name><surname>Stone</surname> <given-names>J</given-names></name><name><surname>Weiss</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A Diacylglycerol-Protein Kinase C-RasGRP1 Pathway Directs Ras Activation upon Antigen Receptor Stimulation of T Cells</article-title><source>Molecular and Cellular Biology</source><volume>25</volume><fpage>4426</fpage><lpage>4441</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.11.4426-4441.2005</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitoh</surname> <given-names>H</given-names></name><name><surname>Pu</surname> <given-names>R</given-names></name><name><surname>Cavenagh</surname> <given-names>M</given-names></name><name><surname>Dasso</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>RanBP2 associates with Ubc9p and a modified form of RanGAP1</article-title><source>PNAS</source><volume>94</volume><fpage>3736</fpage><lpage>3741</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.8.3736</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakin</surname> <given-names>V</given-names></name><name><surname>Richter</surname> <given-names>SM</given-names></name><name><surname>Hsiao</surname> <given-names>H-H</given-names></name><name><surname>Urlaub</surname> <given-names>H</given-names></name><name><surname>Melchior</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sumoylation of the GTPase Ran by the RanBP2 SUMO E3 Ligase Complex</article-title><source>Journal of Biological Chemistry</source><volume>290</volume><fpage>23589</fpage><lpage>23602</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.660118</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakowicz-Burkiewicz</surname> <given-names>M</given-names></name><name><surname>Nishanth</surname> <given-names>G</given-names></name><name><surname>Helmuth</surname> <given-names>U</given-names></name><name><surname>Drögemüller</surname> <given-names>K</given-names></name><name><surname>Busch</surname> <given-names>DH</given-names></name><name><surname>Utermöhlen</surname> <given-names>O</given-names></name><name><surname>Naumann</surname> <given-names>M</given-names></name><name><surname>Deckert</surname> <given-names>M</given-names></name><name><surname>Schlüter</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Protein Kinase C-θ Critically Regulates the Proliferation and Survival of Pathogen-Specific T Cells in Murine Listeriosis</article-title><source>The Journal of Immunology</source><volume>180</volume><fpage>5601</fpage><lpage>5612</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.8.5601</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salek-Ardakani</surname> <given-names>S</given-names></name><name><surname>So</surname> <given-names>T</given-names></name><name><surname>Halteman</surname> <given-names>BS</given-names></name><name><surname>Altman</surname> <given-names>A</given-names></name><name><surname>Croft</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Protein Kinase Cθ Controls Th1 Cells in Experimental Autoimmune Encephalomyelitis</article-title><source>The Journal of Immunology</source><volume>175</volume><fpage>7635</fpage><lpage>7641</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.175.11.7635</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serpeloni</surname> <given-names>M</given-names></name><name><surname>Vidal</surname> <given-names>NM</given-names></name><name><surname>Goldenberg</surname> <given-names>S</given-names></name><name><surname>Ávila</surname> <given-names>AR</given-names></name><name><surname>Hoffmann</surname> <given-names>FG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Comparative genomics of proteins involved in RNA nucleocytoplasmic export</article-title><source>BMC Evolutionary Biology</source><volume>11</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2148-11-7</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>Z</given-names></name><name><surname>Arendt</surname> <given-names>CW</given-names></name><name><surname>Ellmeier</surname> <given-names>W</given-names></name><name><surname>Schaeffer</surname> <given-names>EM</given-names></name><name><surname>Sunshine</surname> <given-names>MJ</given-names></name><name><surname>Gandhi</surname> <given-names>L</given-names></name><name><surname>Annes</surname> <given-names>J</given-names></name><name><surname>Petrzilka</surname> <given-names>D</given-names></name><name><surname>Kupfer</surname> <given-names>A</given-names></name><name><surname>Schwartzberg</surname> <given-names>PL</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes</article-title><source>Nature</source><volume>404</volume><fpage>402</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1038/35006090</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutcliffe</surname> <given-names>EL</given-names></name><name><surname>Bunting</surname> <given-names>KL</given-names></name><name><surname>He</surname> <given-names>YQ</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Phetsouphanh</surname> <given-names>C</given-names></name><name><surname>Seddiki</surname> <given-names>N</given-names></name><name><surname>Zafar</surname> <given-names>A</given-names></name><name><surname>Hindmarsh</surname> <given-names>EJ</given-names></name><name><surname>Parish</surname> <given-names>CR</given-names></name><name><surname>Kelleher</surname> <given-names>AD</given-names></name><name><surname>McInnes</surname> <given-names>RL</given-names></name><name><surname>Taya</surname> <given-names>T</given-names></name><name><surname>Milburn</surname> <given-names>PJ</given-names></name><name><surname>Rao</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Chromatin-Associated Protein Kinase C-θ Regulates an Inducible Gene Expression Program and MicroRNAs in Human T Lymphocytes</article-title><source>Molecular Cell</source><volume>41</volume><fpage>704</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2011.02.030</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutcliffe</surname> <given-names>EL</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Zafar</surname> <given-names>A</given-names></name><name><surname>Hardy</surname> <given-names>K</given-names></name><name><surname>Ghildyal</surname> <given-names>R</given-names></name><name><surname>McCuaig</surname> <given-names>R</given-names></name><name><surname>Norris</surname> <given-names>N</given-names></name><name><surname>Lim</surname> <given-names>PS</given-names></name><name><surname>Milburn</surname> <given-names>PJ</given-names></name><name><surname>Casarotto</surname> <given-names>M</given-names></name><name><surname>Denyer</surname> <given-names>G</given-names></name><name><surname>Rao</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Chromatinized Protein Kinase C-θ: Can It Escape the Clutches of NF-κB?</article-title><source>Frontiers in Immunology</source><volume>3</volume><elocation-id>260</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2012.00260</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swaminathan</surname> <given-names>S</given-names></name><name><surname>Kiendl</surname> <given-names>F</given-names></name><name><surname>Körner</surname> <given-names>R</given-names></name><name><surname>Lupetti</surname> <given-names>R</given-names></name><name><surname>Hengst</surname> <given-names>L</given-names></name><name><surname>Melchior</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>RanGAP1*SUMO1 is phosphorylated at the onset of mitosis and remains associated with RanBP2 upon NPC disassembly</article-title><source>Journal of Cell Biology</source><volume>164</volume><fpage>965</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1083/jcb.200309126</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname> <given-names>E</given-names></name><name><surname>Hieda</surname> <given-names>M</given-names></name><name><surname>Katahira</surname> <given-names>J</given-names></name><name><surname>Yoneda</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Phosphorylation of RanGAP1 Stabilizes Its Interaction with Ran and RanBP1</article-title><source>Cell Structure and Function</source><volume>30</volume><fpage>69</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1247/csf.30.69</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Tetenbaum-Novatt</surname> <given-names>J</given-names></name><name><surname>Rout</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The mechanism of nucleocytoplasmic transport through the nuclear pore complex</article-title><conf-name>Cold Spring Harbor Symposia on Quantitative Biology</conf-name><fpage>567</fpage><lpage>584</lpage></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomasi</surname> <given-names>ML</given-names></name><name><surname>Ramani</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>SUMOylation and phosphorylation cross-talk in hepatocellular carcinoma</article-title><source>Translational Gastroenterology and Hepatology</source><volume>3</volume><elocation-id>20</elocation-id><pub-id pub-id-type="doi">10.21037/tgh.2018.04.04</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tosi</surname> <given-names>S</given-names></name><name><surname>Bardia</surname> <given-names>L</given-names></name><name><surname>Filgueira</surname> <given-names>MJ</given-names></name><name><surname>Calon</surname> <given-names>A</given-names></name><name><surname>Colombelli</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>LOBSTER: an environment to design bioimage analysis workflows for large and complex fluorescence microscopy data</article-title><source>Bioinformatics</source><volume>36</volume><fpage>2634</fpage><lpage>2635</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btz945</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Watt</surname> <given-names>PJ</given-names></name><name><surname>Chi</surname> <given-names>A</given-names></name><name><surname>Stelma</surname> <given-names>T</given-names></name><name><surname>Stowell</surname> <given-names>C</given-names></name><name><surname>Strydom</surname> <given-names>E</given-names></name><name><surname>Carden</surname> <given-names>S</given-names></name><name><surname>Angus</surname> <given-names>L</given-names></name><name><surname>Hadley</surname> <given-names>K</given-names></name><name><surname>Lang</surname> <given-names>D</given-names></name><name><surname>Wei</surname> <given-names>W</given-names></name><name><surname>Birrer</surname> <given-names>MJ</given-names></name><name><surname>Trent</surname> <given-names>JO</given-names></name><name><surname>Leaner</surname> <given-names>VD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic</article-title><source>Molecular Cancer Therapeutics</source><volume>15</volume><fpage>560</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-15-0052</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Appen</surname> <given-names>A</given-names></name><name><surname>Kosinski</surname> <given-names>J</given-names></name><name><surname>Sparks</surname> <given-names>L</given-names></name><name><surname>Ori</surname> <given-names>A</given-names></name><name><surname>DiGuilio</surname> <given-names>AL</given-names></name><name><surname>Vollmer</surname> <given-names>B</given-names></name><name><surname>Mackmull</surname> <given-names>M-T</given-names></name><name><surname>Banterle</surname> <given-names>N</given-names></name><name><surname>Parca</surname> <given-names>L</given-names></name><name><surname>Kastritis</surname> <given-names>P</given-names></name><name><surname>Buczak</surname> <given-names>K</given-names></name><name><surname>Mosalaganti</surname> <given-names>S</given-names></name><name><surname>Hagen</surname> <given-names>W</given-names></name><name><surname>Andres-Pons</surname> <given-names>A</given-names></name><name><surname>Lemke</surname> <given-names>EA</given-names></name><name><surname>Bork</surname> <given-names>P</given-names></name><name><surname>Antonin</surname> <given-names>W</given-names></name><name><surname>Glavy</surname> <given-names>JS</given-names></name><name><surname>Bui</surname> <given-names>KH</given-names></name><name><surname>Beck</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>In situ structural analysis of the human nuclear pore complex</article-title><source>Nature</source><volume>526</volume><fpage>140</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1038/nature15381</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wälde</surname> <given-names>S</given-names></name><name><surname>Thakar</surname> <given-names>K</given-names></name><name><surname>Hutten</surname> <given-names>S</given-names></name><name><surname>Spillner</surname> <given-names>C</given-names></name><name><surname>Nath</surname> <given-names>A</given-names></name><name><surname>Rothbauer</surname> <given-names>U</given-names></name><name><surname>Wiemann</surname> <given-names>S</given-names></name><name><surname>Kehlenbach</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The Nucleoporin Nup358/RanBP2 Promotes Nuclear Import in a Cargo- and Transport Receptor-Specific Manner</article-title><source>Traffic</source><volume>13</volume><fpage>218</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0854.2011.01302.x</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Z-Y</given-names></name><name><surname>Sato</surname> <given-names>H</given-names></name><name><surname>Kusam</surname> <given-names>S</given-names></name><name><surname>Sehra</surname> <given-names>S</given-names></name><name><surname>Toney</surname> <given-names>LM</given-names></name><name><surname>Dent</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Regulation of IL-10 Gene Expression in Th2 Cells by Jun Proteins</article-title><source>The Journal of Immunology</source><volume>174</volume><fpage>2098</fpage><lpage>2105</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.174.4.2098</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X-D</given-names></name><name><surname>Gong</surname> <given-names>Y</given-names></name><name><surname>Chen</surname> <given-names>Z-L</given-names></name><name><surname>Gong</surname> <given-names>B-N</given-names></name><name><surname>Xie</surname> <given-names>J-J</given-names></name><name><surname>Zhong</surname> <given-names>C-Q</given-names></name><name><surname>Wang</surname> <given-names>Q-L</given-names></name><name><surname>Diao</surname> <given-names>L-H</given-names></name><name><surname>Xu</surname> <given-names>A</given-names></name><name><surname>Han</surname> <given-names>J</given-names></name><name><surname>Altman</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>TCR-induced sumoylation of the kinase PKC-θ controls T cell synapse organization and T cell activation</article-title><source>Nature Immunology</source><volume>16</volume><fpage>1195</fpage><lpage>1203</lpage><pub-id pub-id-type="doi">10.1038/ni.3259</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname> <given-names>A</given-names></name><name><surname>Flotho</surname> <given-names>A</given-names></name><name><surname>Melchior</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The RanBP2/RanGAP1∗SUMO1/Ubc9 Complex Is a Multisubunit SUMO E3 Ligase</article-title><source>Molecular Cell</source><volume>46</volume><fpage>287</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2012.02.017</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>J</given-names></name><name><surname>Han</surname> <given-names>X</given-names></name><name><surname>Zhao</surname> <given-names>C</given-names></name><name><surname>Canonigo-Balancio</surname> <given-names>AJ</given-names></name><name><surname>Yates</surname> <given-names>JR</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Lillemeier</surname> <given-names>BF</given-names></name><name><surname>Altman</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Phosphotyrosine-dependent interaction between the kinases pkcθ and Zap70 promotes proximal TCR signaling</article-title><source>Science Signaling</source><volume>12</volume><elocation-id>eaar3349</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.aar3349</pub-id><pub-id pub-id-type="pmid">30992398</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Matunis</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>SUMO modification through rapamycin-mediated heterodimerization reveals a dual role for Ubc9 in targeting RanGAP1 to nuclear pore complexes</article-title><source>Experimental Cell Research</source><volume>312</volume><fpage>1042</fpage><lpage>1049</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2005.12.031</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.67123.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Zúñiga-Pflücker</surname><given-names>Juan Carlos</given-names></name><role>Reviewing Editor</role><aff><institution>University of Toronto, Sunnybrook Research Institute</institution><country>Canada</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Zúñiga-Pflücker</surname><given-names>Juan Carlos</given-names> </name><role>Reviewer</role><aff><institution>University of Toronto, Sunnybrook Research Institute</institution><country>Canada</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.03.10.434793">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.03.10.434793v1.full">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This paper is of interest for immunologists studying antigen receptor signaling and scientists interested in nuclear import. The work provides a novel molecular mechanism linking antigen receptor signalling to an indirect nuclear transport mechanism for regulating localisation of multiple key transcription factors for the T cell immune response during early activation.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;TCR signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 NPC subcomplex via phosphorylation of RanGAP1 by PKC-θ&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including JC Zúñiga-Pflücker as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Jonathan Cooper as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) A common concern was the need to show whether forced expression of activated RanGAP1 could rescue NPC function in PKC-θ KO T cells, which would strengthen the manuscript and the conclusion that the RanBP2 complex formation is the key step downstream of PKC-θ signalling that is regulating nuclear transport of transcription factors.</p><p>2) The authors should address whether the PKC-θ defect in nuclear transport is a generalized effect on many proteins/RNA beyond the transcription factors that were measured and reported.</p><p>3) Limiting the conclusions to the timeframe analyzed would be more appropriate.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1) The authors show ERK phosphorylation in most of their whole cell lysate preparations (e.g., Figure 1i and others), likely to indicate that the cells used for the lysates had in fact undergone activation. However, it is interesting that in PKC-θ deficient (Prkcq-/-) samples there appears to be a significant reduction in the levels of phosho-ERK, was this expected, or was this due to unanticipated regulation by PKC-θ of ERK activation or is this due to some other feedback event. The authors should discuss their interpretation of this phenomenon.</p><p>2) The authors point out that the results shown in Figure 3D, 3F, looking at the role of PKC-θ in thymocytes are consistent with previous results showing that thymocytes did not require PKC-θ for their maturation (PMID: 10746729); however, later studies (PMID: 18802072) showed that PKC-θ can play a role an important role in thymocyte selection. This role for PKC-θ should be discussed, in particular in light of the lowered ERK-phosphorylation seen in the thymocyte samples from the Prkcq-/- mice. Also, this begs the question as to how the NPC is regulated and able to bring in AP1, NFkB and NFAT in thymocytes without PKC-θ.</p><p>3) The legend for Figure 6 should mention that the cells being analyzed are control and gene-modified Jurkat cells.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>PKC-θ is a critical signaling molecule downstream of T cell receptor (TCR), and required for T cell activation via regulating the activation of transcription factors including AP-1, NF-κB and NFAT. This manuscript revealed a novel function of PKC-θ in the regulation of the nuclear translocation of these transcription factors via nuclear pore complexes. This novel perspective for PKC-θ function advances our understanding T cell activation. Although the manuscript provided many evidence to support the conclusion, however there are some concerns:</p><p>1. Importin-β has minimum binding to NPC in PKC-θ KO T cells, does this means that there is almost no importin-β-dependent transportation in PKC-θ KO which is alive and many nuclear proteins and cytoplasm mRNA need to be transported. Is there a way to measure overall importin-β-mediated nucleo-cytoplasmic transportation?</p><p>2. Does importin-β mediates transportation both ways, nucleus to cytoplasmic, and cytoplasmic to nucleus? If that is the case, does the two-way transportation are all affected by PKC-θ. There should be a way to monitor importin-β-dependent transportation each way.</p><p>3. It is mentioned that PKC-θ may promote c-Jun nuclear import, but not its phosphorylation per se, suggesting that it regulates AP-1 activation primarily by controlling the function of the NPC. This is a very interesting suggestion. To support this possibility, first, the c-Jun phosphorylation in PKC-θ KO T cells should be measured. In addition, does constitutively active JNK phosphorylate and activate c-Jun in PKC-θ KO T cells?</p><p>4. The authors should compare RanGAP1AA and RanGAP1EE in the regulation of AP-1, NFAT and NF-κB nuclear translocation in WT and PKC-θ KO T cells. In addition, as controls, they should monitor transport of other nuclear proteins, particularly those constitutively transported. It is necessary to have more evidence that PKC-θ regulates NPC import specifically, and not generally affect NPC function so as to inhibit cell survival.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>1) At points the methods section is lacking in detail – the manuscript figures should be checked to verify that all procedures used are adequately described in the methods section – for example, it is not specified how plasma membrane was purified for Figure 1A-B (best guess from methods is that this is the cytoplasmic fraction? – this needs clarification either way); there is no detail about how transfections were performed beyond the statement cells were &quot;electroporated&quot;, and no reference to how CRISPR/Cas9 editing of Jurkat cell line to generate RanGAP1 knockdown cells was performed (this is only mentioned in the figure legend for Figure S6 with no further details).</p><p>2) In Figure 2F legend it says that PKC-θ mutant K325R/K506R is one of the mutants used in this experiment however there is not data for this shown in the figure.</p><p>3) The AA, EE abbreviations used in the figures 4-6 were only defined in the main text. If this abbreviation could be included in the figure legends as well this would make figures easier to examine and interpret.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.67123.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) A common concern was the need to show whether forced expression of activated RanGAP1 could rescue NPC function in PKC-θ KO T cells, which would strengthen the manuscript and the conclusion that the RanBP2 complex formation is the key step downstream of PKC-θ signalling that is regulating nuclear transport of transcription factors.</p></disp-quote><p>As suggested, we transfected PKCθ-knockdown Jurkat T cells or transduced murine <italic>Prkcq</italic><sup>-/-</sup> splenic T cells with a constitutively active RanGAP1-EE mutant or negative control RanGAP1-AA mutant expression vectors and analyzed the rescue of NPC function. Forced expression of RanGAP1-EE rescued the nuclear import of c-Jun and importin-β, but not of NFATc1 or p65. The inability to rescue the nuclear translocation of NFATc1 and p65 is expected because their upstream signaling pathways are known to be disrupted in <italic>Prkcq</italic><sup>-/-</sup> T cells (Pfeifhofer et al., 2003; Sun et al., 2000). Thus, we conclude that RanBP2 subcomplex formation is the key step downstream of PKCθ signaling, which regulates NPC function, including the nuclear import of c-Jun. The results of this experiment (new Figure 8) are highlighted in in the main text, p. 13.</p><disp-quote content-type="editor-comment"><p>2) The authors should address whether the PKC-θ defect in nuclear transport is a generalized effect on many proteins/RNA beyond the transcription factors that were measured and reported.</p></disp-quote><p>To address this question, we repeated the subcellular fractionation experiment and compared the nuclear translocation of additional proteins in wild-type and PKCθ-knockdown Jurkat T cells (new Figure 7). We found that PKCθ-RanGAP signaling axis is differentially required in different nuclear transport pathways. Specifically, we tested importin-β1-dependent proteins, including RNA exosome complex subunit Dis3, ribosome subunits RPS3 and RPL26, tumor suppressor p53, histone H1; Ran-dependent but importin-β1-independent proteins, including histones (H2B, H3) and protein/RNA export receptor CRM1; and the mRNA export receptor NXF1 which is Ran-independent (Bernardes and Chook, 2020; Serpeloni, Vidal, Goldenberg, Avila, and Hoffmann, 2011).</p><p>We found that following PKCθ knockdown in resting T cells, the nuclear import of Dis3, RPS3 and RPL26, and the nuclear export of CRM1 were decreased, consistent with their requirement for importin β1 or the Ran system; however, the Ran-independent NXF1 also displayed nuclear retention. In TCR-activated cells, PKCθ knockdown did not affect the nuclear transport of CRM1, Dis3, RPS3, or RPL26, implying that under activation conditions, other signaling pathways may overcome the effect of PKCθ deficiency on nuclear transport (such as Dis3) or result in a phenotype similar to that of siPKCθ (such as CRM1). However, TCR stimulation did not alleviate the siPKCθ-induced defects on importin-β1 nuclear import or NXF1 nuclear export. Interestingly, independent of the stimulation status, PKCθ knockdown did not affect the nuclear transport of histones. Moreover, the nuclear import of stimulation-induced p53 was also not affected by siPKCθ. In summary, neither PKCθ nor TCR signaling regulates histones translocation; in resting cells, the importin-β1- or Ran-dependent nuclear transport pathways we tested, with the exception of histones, are dependent on PKCθ; in activated cells, PKCθ is dispensable for their nuclear transport, except for the nuclear transport of importin-β1; and PKC-θ is required for NXF1 transport under both statuses. Thus, the PKCθ-RanGAP signaling axis is differential required in different nuclear transport pathways. These results are described and discussed in the main text, p. 12-13, p. 15.</p><disp-quote content-type="editor-comment"><p>3) Limiting the conclusions to the timeframe analyzed would be more appropriate.</p></disp-quote><p>We addressed this comment by repeating the experiments analyzing RanGAP1 binding to NPCs and of c-Jun nuclear translocation in PKCθ-deficient cells following TCR stimulation for a longer time (12 hours). The results were similar to those obtained after a 15-minute stimulation, namely, PKCθ deficiency led to a reduction of RanGAP1 binding to NPC and c-Jun nuclear translocation, suggesting that there is no compensation even after a 12-hour stimulation period. This result validates our original conclusion. The results are shown in Figure 3—figure supplement 1G, H, and are described in detail in the main text, p. 9.<italic>Reviewer #1 (Recommendations for the authors):</italic></p><disp-quote content-type="editor-comment"><p>1) The authors show ERK phosphorylation in most of their whole cell lysate preparations (e.g., Figure 1i and others), likely to indicate that the cells used for the lysates had in fact undergone activation. However, it is interesting that in PKC-θ deficient (Prkcq-/-) samples there appears to be a significant reduction in the levels of phosho-ERK, was this expected, or was this due to unanticipated regulation by PKC-θ of ERK activation or is this due to some other feedback event. The authors should discuss their interpretation of this phenomenon.</p></disp-quote><p>The defective TCR-induced ERK activation in <italic>Prkcq</italic><sup>-/-</sup> T cells was expected since it has been reported that, upon TCR stimulation, PKCθ activates ERK via phosphorylating RasGRP1 to drive Ras-Erk activation (Mol Cell Biol. 2005, 25:4426-4441.). We have added this information and the discussion and highlighted in the main text, p. 8, p. 16-17.</p><disp-quote content-type="editor-comment"><p>2) The authors point out that the results shown in Figure 3D, 3F, looking at the role of PKC-θ in thymocytes are consistent with previous results showing that thymocytes did not require PKC-θ for their maturation (PMID: 10746729); however, later studies (PMID: 18802072) showed that PKC-θ can play a role an important role in thymocyte selection. This role for PKC-θ should be discussed, in particular in light of the lowered ERK-phosphorylation seen in the thymocyte samples from the Prkcq-/- mice. Also, this begs the question as to how the NPC is regulated and able to bring in AP1, NFkB and NFAT in thymocytes without PKC-θ.</p></disp-quote><p>As suggested, we have now discussed the role for PKCθ in thymocyte selection in more detail (p. 16-17). While the defects of NPC assembly and of AP-1, NF-κB and NFAT activation could be compensated by other PKC isoforms, such as PKCη (Figure 3F, J; Altman and Kong, 2016; Fu et al., 2011; Morley et al., 2008; Sun et al., 2000), the non-redundant role of PKCθ in TCR-induced ERK activation reveals that PKCθ is critical for positive selection as well as for the activation of mature T cells (Altman and Kong, 2016; Morley et al., 2008). Indeed, a personal communication with Dr. G. Fu who reported the cooperation between PKCη and PKCθ in thymic selection (Fu et al., Sci Signal., 2011), confirmed that PKCη deficiency had no impact on ERK activation in thymocytes, although it did impair TCR-induced NF-κB activation and Ca<sup>2+</sup> signaling.</p><disp-quote content-type="editor-comment"><p>3) The legend for Figure 6 should mention that the cells being analyzed are control and gene-modified Jurkat cells.</p></disp-quote><p>The requested information has been added in the Figure 6 legend.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>PKC-θ is a critical signaling molecule downstream of T cell receptor (TCR), and required for T cell activation via regulating the activation of transcription factors including AP-1, NF-κB and NFAT. This manuscript revealed a novel function of PKC-θ in the regulation of the nuclear translocation of these transcription factors via nuclear pore complexes. This novel perspective for PKC-θ function advances our understanding T cell activation. Although the manuscript provided many evidence to support the conclusion, however there are some concerns:</p><p>1. Importin-β has minimum binding to NPC in PKC-θ KO T cells, does this means that there is almost no importin-β-dependent transportation in PKC-θ KO which is alive and many nuclear proteins and cytoplasm mRNA need to be transported. Is there a way to measure overall importin-β-mediated nucleo-cytoplasmic transportation?</p></disp-quote><p>Please see our response to comment #2 in the Essential revisions section above.</p><disp-quote content-type="editor-comment"><p>2. Does importin-β mediates transportation both ways, nucleus to cytoplasmic, and cytoplasmic to nucleus? If that is the case, does the two way transportation are all affected by PKC-θ. There should be a way to monitor importin-β-dependent transportation each way.</p></disp-quote><p>We addressed this question by analyzing the effect of PKCθ deficiency on the fate of Ran-dependent protein/RNA export receptor (CRM1), both Ran- and importin-β-dependent cargos, namely, ribosome subunits, RNA exosome subunit Dis3, histone H1, etc., and Ran-independent mRNA export receptor, NXF1. The results are shown in new Figure 7 and described in p. 12-13, p. 15.</p><disp-quote content-type="editor-comment"><p>3. It is mentioned that PKC-θ may promote c-Jun nuclear import, but not its phosphorylation per se, suggesting that it regulates AP-1 activation primarily by controlling the function of the NPC. This is a very interesting suggestion. To support this possibility, first, the c-Jun phosphorylation in PKC-θ KO T cells should be measured. In addition, does constitutively active JNK phosphorylate and activate c-Jun in PKC-θ KO T cells?</p></disp-quote><p>We analyzed the phosphorylation of JNK and c-Jun in PKC-θ KO T cells and found that PKC-θ deficiency did not impair their activation (Figure 3—figure supplement 1C-D).</p><disp-quote content-type="editor-comment"><p>4. The authors should compare RanGAP1AA and RanGAP1EE in the regulation of AP-1, NFAT and NF-κB nuclear translocation in WT and PKC-θ KO T cells. In addition, as controls, they should monitor transport of other nuclear proteins, particularly those constitutively transported. It is necessary to have more evidence that PKC-θ regulates NPC import specifically, and not generally affect NPC function so as to inhibit cell survival.</p></disp-quote><p>As suggested, we analyzed the effect of RanGAP1 AA and EE mutants on AP-1, NFAT and NF-κB nuclear translocation in WT and PKCθ KO or KD T cells (new Figure 8). In WT T cells, RanGAP1AA and EE did not affect the translocation of these transcription factors since the NPC is already occupied by endogenous RanGAP1-SUMO1. In PKCθ-deficient cells, RanGAP1EE, but not RanGAP1AA, could rescue c-Jun’s nuclear import. None of these mutants rescued the nuclear translocation of NFAT and NF-κB because, as discussed above, they are regulated by upstream, TCR-proximal and PKCθ-dependent signals.</p><p>Please also see our response above to comment #2 in the Essential revision section, and the new Figure 7.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>1) At points the methods section is lacking in detail – the manuscript figures should be checked to verify that all procedures used are adequately described in the methods section – for example, it is not specified how plasma membrane was purified for Figure 1A-B (best guess from methods is that this is the cytoplasmic fraction? – this needs clarification either way); there is no detail about how transfections were performed beyond the statement cells were &quot;electroporated&quot;, and no reference to how CRISPR/Cas9 editing of Jurkat cell line to generate RanGAP1 knockdown cells was performed (this is only mentioned in the figure legend for Figure S6 with no further details).</p></disp-quote><p>We apologize for this omission. We have now added the protocol of plasma membrane purification for Figure 1A, B in the Materials and methods section on p. 23; the electroporation information on p. 22; the protocol of CRISPR/Cas9 editing on p. 26.</p><disp-quote content-type="editor-comment"><p>2) In Figure 2F legend it says that PKC-θ mutant K325R/K506R is one of the mutants used in this experiment however there is not data for this shown in the figure.</p></disp-quote><p>We apologize for incorrectly labelling the figure. The PKCθ-2KR refers to the K325R/K506R mutant. We have added this information in the Figure 2F legend.</p><disp-quote content-type="editor-comment"><p>3) The AA, EE abbreviations used in the figures 4-6 were only defined in the main text. If this abbreviation could be included in the figure legends as well this would make figures easier to examine and interpret.</p></disp-quote><p>As suggested, the AA, EE abbreviations are now defined in the figure legends for Figures 4-6.</p></body></sub-article></article>